

    <!DOCTYPE html>
<html class="">

        
<head>
    <title>Recent advances in understanding vitiligo | F1000Research</title>
    <meta charset="utf-8">
    <!--<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>-->
    <!--<meta lang="$locale">-->
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="google-site-verification" content="9-QVycOO2_ob3Z9QzRmXv2CF08A9oyYXqWyTiVdKPlU" />
    <!-- This is commented out to fix display problems on mobile devices.
    We may use it again once we implement a responsive design that supports native device resolutions.
    <meta name="viewport" content="width=device-width"> -->

    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">



    <link rel="alternate" title="Recent articles published in F1000Research" href="/rss" type="application/rss+xml">
            <link rel="alternate" type="application/pdf" title="PDF" href="https://f1000research.com/articles/5-2234/pdf"/>
        <link rel="canonical" href="https://f1000research.com/articles/5-2234" />
    
            <meta name="description" content="Read the original article in full on F1000Research: Recent advances in understanding vitiligo" />
    
            <meta name="og:title" content="F1000Research Article: Recent advances in understanding vitiligo.">
            <meta name="og:description" content="Read the latest article version by Prashiela Manga, Nada Elbuluk, Seth J. Orlow, at F1000Research.">
            <meta name="og:image" content="/img/sharing/og_research.png">
            <meta name="version-id" content="9656">
            <meta name="article-id" content="8976">
            <meta name="dc.title" content="Recent advances in understanding vitiligo">
            <meta name="dc.description" content="Vitiligo, an acquired depigmentation disorder, manifests as white macules on the skin and can cause significant psychological stress and stigmatization. Recent advances have shed light on key components that drive disease onset and progression as well as therapeutic approaches. Vitiligo can be triggered by stress to the melanin pigment-producing cells of the skin, the melanocytes. The triggers, which range from sunburn to mechanical trauma and chemical exposures, ultimately cause an autoimmune response that targets melanocytes, driving progressive skin depigmentation. The most significant progress in our understanding of disease etiology has been made on three fronts: (1) identifying cellular responses to stress, including antioxidant pathways and the unfolded protein response (UPR), as key players in disease onset, (2) characterizing immune responses that target melanocytes and drive disease progression, and (3) identifying major susceptibility genes. The current model for vitiligo pathogenesis postulates that oxidative stress causes cellular disruptions, including interruption of protein maturation in the endoplasmic reticulum (ER), leading to the activation of the UPR and expression of UPR-regulated chemokines such as interleukin 6 (IL-6) and IL-8. These chemokines recruit immune components to the skin, causing melanocytes to be targeted for destruction. Oxidative stress can further increase melanocyte targeting by promoting antigen presentation. Two key components of the autoimmune response that promote disease progression are the interferon (IFN)-&gamma;/CXCL10 axis and IL-17-mediated responses. Several genome-wide association studies support a role for these pathways, with the antioxidant gene NRF2 , UPR gene XBP1 , and numerous immune-related genes including class I and class II major histocompatibility genes associated with a risk for developing vitiligo. Novel approaches to promote repigmentation in vitiligo are being investigated and may yield effective, long-lasting therapies.">
            <meta name="dc.subject" content="Vitiligo, melanocyte, oxidative stress, IFN-&gamma;, Phototherapy, ">
            <meta name="dc.creator" content="Manga, Prashiela">
            <meta name="dc.creator" content="Elbuluk, Nada">
            <meta name="dc.creator" content="Orlow, Seth J.">
            <meta name="dc.date" content="2016/09/06">
            <meta name="dc.identifier" content="doi:10.12688/f1000research.8976.1">
            <meta name="dc.source" content="F1000Research 2016 5:2234">
            <meta name="dc.format" content="text/html">
            <meta name="dc.language" content="en">
            <meta name="dc.publisher" content="F1000 Research Limited">
            <meta name="dc.rights" content="https://creativecommons.org/licenses/by/3.0/igo/">
            <meta name="dc.type" content="text">
            <meta name="prism.keyword" content="Vitiligo ">
            <meta name="prism.keyword" content=" melanocyte ">
            <meta name="prism.keyword" content=" oxidative stress ">
            <meta name="prism.keyword" content=" IFN-&gamma; ">
            <meta name="prism.keyword" content=" Phototherapy ">
            <meta name="prism.publication.Name" content="F1000Research">
            <meta name="prism.publicationDate" content="2016/09/06">
            <meta name="prism.volume" content="5">
            <meta name="prism.number" content="2234">
            <meta name="prism.versionIdentifier" content="1">
            <meta name="prism.doi" content="10.12688/f1000research.8976.1">
            <meta name="prism.url" content="https://f1000research.com/articles/5-2234">
            <meta name="citation_title" content="Recent advances in understanding vitiligo">
            <meta name="citation_abstract" content="Vitiligo, an acquired depigmentation disorder, manifests as white macules on the skin and can cause significant psychological stress and stigmatization. Recent advances have shed light on key components that drive disease onset and progression as well as therapeutic approaches. Vitiligo can be triggered by stress to the melanin pigment-producing cells of the skin, the melanocytes. The triggers, which range from sunburn to mechanical trauma and chemical exposures, ultimately cause an autoimmune response that targets melanocytes, driving progressive skin depigmentation. The most significant progress in our understanding of disease etiology has been made on three fronts: (1) identifying cellular responses to stress, including antioxidant pathways and the unfolded protein response (UPR), as key players in disease onset, (2) characterizing immune responses that target melanocytes and drive disease progression, and (3) identifying major susceptibility genes. The current model for vitiligo pathogenesis postulates that oxidative stress causes cellular disruptions, including interruption of protein maturation in the endoplasmic reticulum (ER), leading to the activation of the UPR and expression of UPR-regulated chemokines such as interleukin 6 (IL-6) and IL-8. These chemokines recruit immune components to the skin, causing melanocytes to be targeted for destruction. Oxidative stress can further increase melanocyte targeting by promoting antigen presentation. Two key components of the autoimmune response that promote disease progression are the interferon (IFN)-&gamma;/CXCL10 axis and IL-17-mediated responses. Several genome-wide association studies support a role for these pathways, with the antioxidant gene NRF2 , UPR gene XBP1 , and numerous immune-related genes including class I and class II major histocompatibility genes associated with a risk for developing vitiligo. Novel approaches to promote repigmentation in vitiligo are being investigated and may yield effective, long-lasting therapies.">
            <meta name="citation_description" content="Vitiligo, an acquired depigmentation disorder, manifests as white macules on the skin and can cause significant psychological stress and stigmatization. Recent advances have shed light on key components that drive disease onset and progression as well as therapeutic approaches. Vitiligo can be triggered by stress to the melanin pigment-producing cells of the skin, the melanocytes. The triggers, which range from sunburn to mechanical trauma and chemical exposures, ultimately cause an autoimmune response that targets melanocytes, driving progressive skin depigmentation. The most significant progress in our understanding of disease etiology has been made on three fronts: (1) identifying cellular responses to stress, including antioxidant pathways and the unfolded protein response (UPR), as key players in disease onset, (2) characterizing immune responses that target melanocytes and drive disease progression, and (3) identifying major susceptibility genes. The current model for vitiligo pathogenesis postulates that oxidative stress causes cellular disruptions, including interruption of protein maturation in the endoplasmic reticulum (ER), leading to the activation of the UPR and expression of UPR-regulated chemokines such as interleukin 6 (IL-6) and IL-8. These chemokines recruit immune components to the skin, causing melanocytes to be targeted for destruction. Oxidative stress can further increase melanocyte targeting by promoting antigen presentation. Two key components of the autoimmune response that promote disease progression are the interferon (IFN)-&gamma;/CXCL10 axis and IL-17-mediated responses. Several genome-wide association studies support a role for these pathways, with the antioxidant gene NRF2 , UPR gene XBP1 , and numerous immune-related genes including class I and class II major histocompatibility genes associated with a risk for developing vitiligo. Novel approaches to promote repigmentation in vitiligo are being investigated and may yield effective, long-lasting therapies.">
            <meta name="citation_keywords" content="Vitiligo, melanocyte, oxidative stress, IFN-&gamma;, Phototherapy, ">
            <meta name="citation_journal_title" content="F1000Research">
            <meta name="citation_author" content="Prashiela Manga">
            <meta name="citation_author_institution" content="The Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York, NY, 10016, USA">
            <meta name="citation_author" content="Nada Elbuluk">
            <meta name="citation_author_institution" content="The Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York, NY, 10016, USA">
            <meta name="citation_author" content="Seth J. Orlow">
            <meta name="citation_author_institution" content="The Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York, NY, 10016, USA">
            <meta name="citation_publication_date" content="2016/09/06">
            <meta name="citation_volume" content="5">
            <meta name="citation_publication_number" content="2234">
            <meta name="citation_version_number" content="1">
            <meta name="citation_doi" content="10.12688/f1000research.8976.1">
            <meta name="citation_firstpage" content="2234">
            <meta name="citation_pdf_url" content="https://f1000research.com/articles/5-2234/v1/pdf">
    

    
    <link href="/img/favicon-research.ico" rel="shortcut icon" type="image/ico">
    <link href="/img/favicon-research.ico" rel="icon" type="image/ico">

        <link rel="stylesheet" href="/1597255280893/css/mdl/material-design-lite.css" type="text/css" media="all" />
    <link href="https://fonts.googleapis.com/icon?family=Material+Icons" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css?family=Roboto:100,100i,300,300i,400,400i,500,500i,700,700i,900,900i" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/MaterialDesign-Webfont/2.2.43/css/materialdesignicons.min.css" />

        
            
    <link rel="stylesheet" href="/1597255280893/css/F1000Research.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/animation.css" type="text/css" media="all" />

        <!--[if IE 7]><link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons-ie7.css" media="all" /><![endif]-->

                    <script>dataLayer = [];</script>
        <!-- Google Tag Manager -->
        <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
        new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
        j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
        'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
        })(window,document,'script','dataLayer','GTM-54Z2SBK');</script>
        <!-- End Google Tag Manager -->
    
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.1/jquery.min.js"></script>
    <script>window.jQuery || document.write('<script src="/js/vendor/jquery-1.8.1.min.js"><\/script>')</script>
    <script src="/1597255280893/js/vendor/modernizr-2.6.1-respond-1.1.0.min.js"></script>
    <script src="/1597255280893/js/shared_scripts/sticky.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/shared_scripts/menu.js"></script>
    <script src="/1597255280893/js/shared_scripts/navbar.js"></script>
    <script src="/1597255280893/js/shared_scripts/platforms.js"></script>
    <script src="/1597255280893/js/shared_scripts/object-polyfills.js"></script>
            <script src="/1597255280893/js/vendor/lodash.min.js"></script>
        <script>CKEDITOR_BASEPATH='https://f1000research.com/js/ckeditor/'</script>
    <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/plugins.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/app/research.js"></script>
    <script>window.reactTheme = 'research';</script>
    <script src="/1597255280893/js/public/bundle.js"></script>

    <script src="/1597255280893/js/app/research.ui.js"></script>
    <script src="/1597255280893/js/app/login.js"></script>
    <script src="/1597255280893/js/app/main.js"></script>
    <script src="/1597255280893/js/app/js-date-format.min.js"></script>
    <script src="/1597255280893/js/app/search.js"></script>
    <script src="/1597255280893/js/app/cookies_warning.js"></script>
    <script src="/1597255280893/js/mdl/mdl.min.js"></script>

    <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
                <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/ckeditor.js"></script>
            <script src="/js/ckeditor/adapters/jquery.js"></script>
                <script src="/js/article/article_scrolling_module.js"></script>
            <script src="/js/article/article_stats.js"></script>
            <script src="/js/article/article.js"></script>
            <script src="/js/shared_scripts/referee_timeline_pagination.js"></script>
            <script src="/js/app/text_editor_controller.js"></script>
            <script src="//s7.addthis.com/js/250/addthis_widget.js#pubid=ra-503e5e99593dc42c"></script>
            <script src="/js/article/article_metrics.js"></script>
        
                                                                            <script>
            if (window.location.hash == '#_=_'){
                window.location = window.location.href.split('#')[0]
            }
        </script>

                    
        
    <!-- pixelId: 1641728616063202 :: assetPixelId: 6034867600215 :: funderPixelId:  -->

            <!-- Facebook pixel code (merged with EP GTM code) -->
        <script>
            !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function()

            {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}
            ;if(!f._fbq)f._fbq=n;
            n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
            t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
            document,'script','https://connect.facebook.net/en_US/fbevents.js');

            fbq('init', '1641728616063202');

            
            fbq('track', "PixelInitialized", {});
        </script>

        <noscript><img height="1" width="1" style="display:none"
            src="https://www.facebook.com/tr?id=1641728616063202&noscript=1&amp;ev=PixelInitialized"
        /></noscript>
        <!-- End Facebook Pixel Code -->
    
                <script>
            (function(h,o,t,j,a,r){
                h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)};
                h._hjSettings={hjid:917825,hjsv:6};
                a=o.getElementsByTagName('head')[0];
                r=o.createElement('script');r.async=1;
                r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv;
                a.appendChild(r);
            })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv=');
        </script>
    
</head>
<body  class="o-page-container no-js p-article o-layout-reset   ">

    
                            <!-- Google Tag Manager (noscript) -->
        <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-54Z2SBK"
        height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
        <!-- End Google Tag Manager (noscript) -->
    
        
    <div class="o-page">

        <div id="notify-container"></div>
        <div id="pageWarning"></div>
        <div id="pageMessage"></div>
        <div id="pageFooterMessage"></div>

                                <div id="f1r-ga-data" data-name="f1r-ga-data" class="f1r-ga-data"
                data-user-registered="false"
                data-user-module=""
                data-current-path=""
                data-location=""
                data-website="F1000Research"
                data-websiteDisplayName="F1000Research">
            </div>
        
                
        
        <div class="header-wrapper   js-navbar-space ">
                            


    










        
                            
    
            



<nav class="c-navbar js-navbar js-mini-nav js-sticky c-navbar--js-sticky c-navbar--userSite c-navbar__platform-bgcolor  c-navbar--bg-f1000research ">

    <div class="c-navbar__content">

                                <div class="c-navbar__extras">
            <div class="o-wrapper">
                <div class="o-actions o-actions--middle c-navbar__extras-row">
                    <div class="o-actions__primary">
                        
                                            </div>
                                    </div>
            </div>
        </div>

        <div class="o-wrapper t-inverted js-sticky-start">

            <div class="c-navbar__branding-row">
                <div class="c-navbar__row">


                                        
                    <div class="c-navbar__primary u-mr--2">

                                                                                                                                                                                                    <a href="/" class="c-navbar__branding u-ib u-middle"   data-test-id="nav_branding"  >
                                <img class="u-ib u-middle" src="/img/research/F1000Research_white_solid.svg" alt="F1000Research">
                            </a>
                                            </div>

                    <div class="c-navbar__secondary c-navbar__row">


                                                
                                                    <form action="/search" class="-navbar__secondary u-mr--2 c-search-form js-search-form u-hide u-show@navbar">
                                <label for="searchInput" class="c-search-form__label _mdl-layout">
                                    <input name="q" type="search" class="c-search-form__input" id="searchInput" placeholder="Search">
                                    <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                </label>
                            </form>
                        
                                                
                                                    <div class="c-navbar__primary u-hide u-show@navbar">
                                <div class="_mdl-layout c-navbar__cta">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--no-shadow mdl-button--multi-line mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                            </div>
                        

                                                
                        <span class="u-hide@navbar _mdl-layout u-nowrap">

                                                            <button type="button" class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" data-focus="#navbar_mob_search_input" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_search_mob"  ><i class="material-icons">search</i></button>
                            
                                                            <button class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon mdl-button--multi-line c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" type="button" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_toggle_mob"  >
                                    <i class="material-icons c-navbar__toggle-open">menu</i>
                                    <i class="material-icons c-navbar__toggle-close">close</i>
                                </button>
                                                    </span>
                    </div>

                </div>
            </div>

                        
                            <div class="c-navbar__menu-row js-navbar-block is-collapsed" id="navbarMenu">

                                                                                                                                                
                                                                    
                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                            

                                                                
                                                                                                                                                                                                                                
                                            
                    <div class="c-navbar__menu-row-content">

                                                                            <div class="u-hide@navbar c-navbar__menu-bar-spacing">
                                <form action="/search" class="c-search-form js-search-form">
                                    <label for="navbar_mob_search_input" class="c-search-form__label _mdl-layout">
                                        <input id="navbar_mob_search_input" name="q" type="search" class="c-search-form__input" placeholder="Search">
                                        <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                    </label>
                                </form>
                            </div>
                        
                        <div class="o-actions o-actions--middle">

                            <div class="o-actions__primary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="main-menu"   role="menubar" aria-label="Main Navigation"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/browse/articles" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="0"
                              data-test-id="nav_browse"                              >Browse</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/gateways" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_gatewaysViewAndBrowse"                              >Gateways & Collections</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="2"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_for-authors"                              >How to Publish</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="How to Publish">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_submit-manuscript"                      href="/for-authors/publish-your-research"
                    role="menuitem"
                    tabindex="0">Submit your Research</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/for-authors/my-submissions"
                    role="menuitem"
                    tabindex="-1">My Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines"                      href="/for-authors/article-guidelines"
                    role="menuitem"
                    tabindex="-1">Article Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines-new-versions"                      href="/for-authors/article-guidelines-new-versions"
                    role="menuitem"
                    tabindex="-1">Article Guidelines (New Versions)</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_data-guidelines"                      href="/for-authors/data-guidelines"
                    role="menuitem"
                    tabindex="-1">Data Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_asset-guidelines"                      href="/for-authors/posters-and-slides-guidelines"
                    role="menuitem"
                    tabindex="-1">Posters and Slides Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_document-guidelines"                      href="/for-authors/document-guidelines"
                    role="menuitem"
                    tabindex="-1">Document Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-processing-charges"                      href="/for-authors/article-processing-charges"
                    role="menuitem"
                    tabindex="-1">Article Processing Charges</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_finding-referees"                      href="/for-authors/tips-for-finding-referees"
                    role="menuitem"
                    tabindex="-1">Finding Article Reviewers</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="3"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_about-contact"                              >About</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="About">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_about-page"                      href="/about"
                    role="menuitem"
                    tabindex="0">How it Works</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_referee-guidelines"                      href="/for-referees/guidelines"
                    role="menuitem"
                    tabindex="-1">For Reviewers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_advisoryPanel"                      href="/advisors"
                    role="menuitem"
                    tabindex="-1">Our Advisors</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_policy-page"                      href="/about/policies"
                    role="menuitem"
                    tabindex="-1">Policies</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_glossary-page"                      href="/glossary"
                    role="menuitem"
                    tabindex="-1">Glossary</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_faqs-page"                      href="/faqs"
                    role="menuitem"
                    tabindex="-1">FAQs</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              u-hide u-show@navbar"
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      u-hide u-show@navbar"
                                          data-test-id="nav_for-developers"                      href="/developers"
                    role="menuitem"
                    tabindex="-1">For Developers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_newsroom-page"                      href="/newsroom"
                    role="menuitem"
                    tabindex="-1">Newsroom</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_contact-page"                      href="/contact"
                    role="menuitem"
                    tabindex="-1">Contact</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="4"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="https://blog.f1000.com/blogs/f1000research/" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                             target="_blank"                                                         tabindex="-1"
                              data-test-id="nav_blog"                              >Blog</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                            <div class="o-actions__secondary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="secondary-items"   role="menubar" aria-label="My Account"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="0"
                              data-test-id="nav_my-research"                              >My Research</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="My Research">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/login?originalPath=/my/submissions"
                    role="menuitem"
                    tabindex="0">Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-email-alerts"                      href="/login?originalPath=/my/email-alerts"
                    role="menuitem"
                    tabindex="-1">Content and Tracking Alerts</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-user-details"                      href="/login?originalPath=/my/user-details"
                    role="menuitem"
                    tabindex="-1">My Details</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/login?originalPath=/articles/5-2234.html" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_sign-in"                              >Sign In</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                                                                                        <div class="_mdl-layout c-navbar__cta u-hide@navbar c-navbar__menu-bar-spacing">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--multi-line mdl-button--no-shadow mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research_mob"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                                                    </div>

                    </div>

                </div>
            
        </div>

    </div>

</nav>
                    </div>

        <div class="content-wrapper o-page__main row ">
            <div id="highlight-area" class="content ">
                





<div id=article-metadata class=hidden> <input type=hidden name=versionId value=9656 /> <input type=hidden id=articleId name=articleId value=8976 /> <input type=hidden id=xmlUrl value="/articles/5-2234/v1/xml"/> <input type=hidden id=xmlFileName value="-5-2234-v1.xml"> <input type=hidden id=article_uuid value=71c621c6-08ce-4004-8ebe-460f2839e177 /> <input type=hidden id=referer value=""/> <input type=hidden id=meta-article-title value="Recent advances in understanding vitiligo"/> <input type=hidden id=workspace-export-url value="https://sciwheel.com/work/api/import/external?doi=10.12688/f1000research.8976.1"/> <input type=hidden id=versionDoi value="10.12688/f1000research.8976.1"/> <input type=hidden id=usePmcStats value=true /> </div> <main class="o-wrapper p-article__wrapper js-wrapper"> <script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "ScholarlyArticle",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://f1000research.com/articles/5-2234"
  },
  "headline": "Recent advances in understanding vitiligo",
  "datePublished": "2016-09-06T10:33:59",
  "dateModified": "2016-09-06T10:33:59",
  "author": [
    {
      "@type": "Person",
      "name": "Prashiela Manga"
    },    {
      "@type": "Person",
      "name": "Nada Elbuluk"
    },    {
      "@type": "Person",
      "name": "Seth J. Orlow"
    }  ],
  "publisher": {
    "@type": "Organization",
    "name": "F1000Research",
    "logo": {
      "@type": "ImageObject",
      "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
      "height": 480,
      "width": 60
    }
  },
  "image": {
    "@type": "ImageObject",
    "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
    "height": 1200,
    "width": 150
  },
  "description": "Vitiligo, an acquired depigmentation disorder, manifests as white macules on the skin and can cause significant psychological stress and stigmatization. Recent advances have shed light on key components that drive disease onset and progression as well as therapeutic approaches. Vitiligo can be triggered by stress to the melanin pigment-producing cells of the skin, the melanocytes. The triggers, which range from sunburn to mechanical trauma and chemical exposures, ultimately cause an autoimmune response that targets melanocytes, driving progressive skin depigmentation. The most significant progress in our understanding of disease etiology has been made on three fronts: (1) identifying cellular responses to stress, including antioxidant pathways and the unfolded protein response (UPR), as key players in disease onset, (2) characterizing immune responses that target melanocytes and drive disease progression, and (3) identifying major susceptibility genes. The current model for vitiligo pathogenesis postulates that oxidative stress causes cellular disruptions, including interruption of protein maturation in the endoplasmic reticulum (ER), leading to the activation of the UPR and expression of UPR-regulated chemokines such as interleukin 6 (IL-6) and IL-8. These chemokines recruit immune components to the skin, causing melanocytes to be targeted for destruction. Oxidative stress can further increase melanocyte targeting by promoting antigen presentation. Two key components of the autoimmune response that promote disease progression are the interferon (IFN)-&gamma;/CXCL10 axis and IL-17-mediated responses. Several genome-wide association studies support a role for these pathways, with the antioxidant gene NRF2, UPR gene XBP1, and numerous immune-related genes including class I and class II major histocompatibility genes associated with a risk for developing vitiligo. Novel approaches to promote repigmentation in vitiligo are being investigated and may yield effective, long-lasting therapies."
}
</script> <div class="o-layout o-layout--right-gutter"> <div id=article_secondary-column class="p-article__main o-layout__item u-font-size--legal u-2/3@article not-expanded "> <div class=float-left> <script type="application/ld+json">
  {
    "@context": "http://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
              {
          "@type": "ListItem",
          "position": "1",
          "item": {
            "@id": "https://f1000research.com/",
            "name": "Home"
          }
        },              {
          "@type": "ListItem",
          "position": "2",
          "item": {
            "@id": "https://f1000research.com/browse/articles",
            "name": "Browse"
          }
        },              {
          "@type": "ListItem",
          "position": "3",
          "item": {
            "@id": "https://f1000research.com/articles/5-2234/v1",
            "name": "Recent advances in understanding vitiligo"
          }
        }          ]
  }
  </script> <div class="breadcrumbs js-breadcrumbs"> <a href="/" class=f1r-standard-link>Home</a> <span class=item_separator></span> <a href="/browse/articles" class=f1r-standard-link>Browse</a> <span class=item_separator></span> Recent advances in understanding vitiligo </div> </div> <div class="article-badges-container u-mb--2"> <div class=crossmark-new> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script> <a data-target=crossmark><img height=30 width=150 src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_horizontal.svg"/></a> </div> <div id=crossmark-dialog style="display: none;" title=""> <iframe id=crossmark-dialog-frame frameborder=0></iframe> </div> <div class=clearfix></div> </div> <div class=article-interaction-container> <div id=main-article-count-box class=article-count-box> <div class="article-metrics-wrapper metrics-icon-wrapper" data-version-id=9656 data-id=8976 data-downloads="" data-views="" data-scholar="10.12688/f1000research.8976.1" data-recommended="" data-doi="10.12688/f1000research.8976.1" data-f1r-ga-helper="Article Page Metrics (Desktop)"> <span class="metrics-on-browse article-metrics-icon f1r-icon icon-89_metrics"></span> <div class="count-title article-metrics-text">ALL Metrics</div> <div class=js-article-metrics-container></div> </div> <div> <div class=count-delimiter></div> <div title="Total views from F1000Research and PubMed Central"> <div class="count-container view-count js-views-count">-</div> <div class=count-title><span class="count-title-icon count-title-views-icon"></span>Views</div> </div> <div class=download-counts hidden> <div class=count-delimiter></div> <div title="Total downloads from F1000Research and PubMed Central"> <div class="count-container js-downloads-count"></div> <div class=count-title><span class="count-title-icon f1r-icon icon-76_download_file"></span>Downloads</div> </div> </div> </div> </div> <div id=main-article-interaction-box class="article-interaction-box has-control-tab"> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-102_download_pdf"></span> <a href="https://f1000research.com/articles/5-2234/v1/pdf?article_uuid=71c621c6-08ce-4004-8ebe-460f2839e177" title="Download PDF" class="button-link download pdf-download-helper" target=_blank>Get PDF</a> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-103_download_xml"></span> <a id=download-xml href="#" class="button-link download" title="Download XML">Get XML</a> </div> </div> <div class="article-interaction-info article-page"> <div class="cite-article-popup-wrapper article-page-interaction-box"> <div class="article-interaction-button cite-article-button" title="Cite this article" data-windowref=cite-article-popup-8976-1> <span class="f1r-icon icon-82_quote"></span> <a href="#" class="button-link cite-article-popup-link" title="Cite Article">Cite</a> </div> <div id=cite-article-popup-8976-1 class="popup-window-wrapper is-hidden"> <div class=cite-popup-background></div> <div class="popup-window top-popup cite-this-article-box research-layout"> <div class="popup-window-title small cite-title">How to cite this article</div> <span id=cite-article-text-8976-1 data-test-id=copy-citation_text> <span class="article-title-and-info in-popup">Manga P, Elbuluk N and Orlow SJ. Recent advances in understanding vitiligo [version 1; peer review: 3 approved]</span>. <i>F1000Research</i> 2016, <b>5</b>(F1000 Faculty Rev):2234 (<a class=new-orange href="https://doi.org/10.12688/f1000research.8976.1" target=_blank>https://doi.org/10.12688/f1000research.8976.1</a>) </span> <div class="popup-window-title small margin-top-20 margin-bottom-20 note"> <strong>NOTE:</strong> it is important to ensure the information in square brackets after the title is included in all citations of this article. </div> <div class=float-right> <button class="secondary no-fill orange-text-and-border margin-right-20 close-cite-popup uppercase">Close</button> <button id=copy-citation-details class="secondary orange copy-cite-article-version uppercase js-clipboard" title="Copy the current citation details to the clipboard." data-clipboard-target="#cite-article-text-8976-1" data-test-id=copy-citation_button>Copy Citation Details</button> </div> </div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-76_download_file"></span> <a id=export-citation href="#" class="button-link download" title="Export Citation">Export</a> </div> <div class="modal-window-wrapper is-hidden"> <div id=export-citation-popup class="modal-window padding-20"> <div class=modal-window-close-button></div> <div class=modal-window-title>Export Citation</div> <div class=modal-window-row> <div> <input type=radio name=export-citation-option value=WORKSPACE /> <span class=radio-label>Sciwheel</span> </div> <div> <input type=radio name=export-citation-option value=ENDNOTE /> <span class=radio-label>EndNote</span> </div> <div> <input type=radio name=export-citation-option value=REF_MANAGER /> <span class=radio-label>Ref. Manager</span> </div> <div> <input type=radio name=export-citation-option value=BIBTEX /> <span class=radio-label>Bibtex</span> </div> <div> <input type=radio name=export-citation-option value=PROCITE /> <span class=radio-label>ProCite</span> </div> <div> <input type=radio name=export-citation-option value=SENTE /> <span class=radio-label>Sente</span> </div> </div> <div class=modal-window-footer> <button class=general-white-orange-button id=export-citation-submit>EXPORT</button> </div> <div class=default-error style="display: none;">Select a format first</div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-90_track"></span> <a class="button-link track-article" data-article-id=8976 id=track-article-signin-8976 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/8976?target=/articles/5-2234/v1">Track</a> </div> </div> <div class="article-interaction-info article-page"> <div class="article-interaction-button email-article"> <span class="f1r-icon icon-6_email"></span> <a href="#" class=button-link title="Email this article">Email</a> </div> <div class="email-article-version-container small-tooltip _chrome-fix"> <div class=close-icon><span class="f1r-icon icon-3_close_big"></span></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=9656 /> <input name=articleId type=hidden value=8976 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-34_share"></span> <a href="#" class="button-link last addthis_button share-article" title="Share this article">Share</a> </div> </div> </div> <div id=article-interaction-control-tab class=article-interaction-control-tab> <div id=hide-article-interaction class=article-interaction-control title="Hide Toolbox">&#9644;</div> <div id=show-article-interaction class="article-interaction-control open" title="Show Toolbox">&#10010;</div> </div> </div> <div class="article-header-information article-page"> <div class="f1r-article-mobile article-heading-bar"></div> <div class="article-type article-display">Review </div> <div class="article-title-and-info article-view highlighted-article" id=anchor-title> <h1>Recent advances in understanding vitiligo</h1><span class=other-info> [version 1; peer review: 3 approved]</span> </div> <div class=article-subtitle></div> <div class=f1r-article-desk> <div class="authors _mdl-layout"><span class="">Prashiela Manga,&nbsp;</span><span class="">Nada Elbuluk,&nbsp;</span><span class=""><a href="mailto:seth.orlow@nyumc.org" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Seth J. Orlow</span></a></span></div> </div> <div class=f1r-article-mobile> <div class="authors _mdl-layout"><span class="">Prashiela Manga,&nbsp;</span><span class="">Nada Elbuluk,&nbsp;</span><span class=""><a href="mailto:seth.orlow@nyumc.org" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Seth J. Orlow</span></a></span></div> </div> <div class=f1r-article-mobile> <div class=article-pubinfo-mobile> PUBLISHED 06 Sep 2016 </div> </div> <span class=Z3988 title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft_id=info:doi/10.12688%2Ff1000research.8976.1"></span> <div class=f1r-article-desk> <div class="contracted-details first"> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> The Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York, NY, 10016, USA<br/> <p> </p> </div> </div> </div> <div class=f1r-article-mobile> <div class="article-page-section-box margin-bottom-40 research-layout"> <span class=box-title> <span class="f1r-icon icon-85_peer_review"></span> OPEN PEER REVIEW </span> <button class="tertiary grey float-right" data-scrollto=article-reports>DETAILS</button> <div class="status-row referee-reports-container"> REVIEWER STATUS <span class=status-icons> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=15346-16120></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=15347-16122></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=15339-16121></span> </span> </div> </div> </div> </div> <h2 class="article-headings article-page-abstract" id=anchor-abstract> <span class="f1r-article-mobile-inline abstract-heading-border"></span> Abstract </h2> <div class="article-abstract article-page-general-text-mobile research-layout"> <div class="abstract-text is-expanded"> Vitiligo, an acquired depigmentation disorder, manifests as white macules on the skin and can cause significant psychological stress and stigmatization. Recent advances have shed light on key components that drive disease onset and progression as well as therapeutic approaches. Vitiligo can be triggered by stress to the melanin pigment-producing cells of the skin, the melanocytes. The triggers, which range from sunburn to mechanical trauma and chemical exposures, ultimately cause an autoimmune response that targets melanocytes, driving progressive skin depigmentation. The most significant progress in our understanding of disease etiology has been made on three fronts: (1) identifying cellular responses to stress, including antioxidant pathways and the unfolded protein response (UPR), as key players in disease onset, (2) characterizing immune responses that target melanocytes and drive disease progression, and (3) identifying major susceptibility genes. The current model for vitiligo pathogenesis postulates that oxidative stress causes cellular disruptions, including interruption of protein maturation in the endoplasmic reticulum (ER), leading to the activation of the UPR and expression of UPR-regulated chemokines such as interleukin 6 (IL-6) and IL-8. These chemokines recruit immune components to the skin, causing melanocytes to be targeted for destruction. Oxidative stress can further increase melanocyte targeting by promoting antigen presentation. Two key components of the autoimmune response that promote disease progression are the interferon (IFN)-/CXCL10 axis and IL-17-mediated responses. Several genome-wide association studies support a role for these pathways, with the antioxidant gene <i>NRF2</i>, UPR gene <i>XBP1</i>, and numerous immune-related genes including class I and class II major histocompatibility genes associated with a risk for developing vitiligo. Novel approaches to promote repigmentation in vitiligo are being investigated and may yield effective, long-lasting therapies. </div> <div class=abstract-for-mobile> <div class="margin-top-30 padding-bottom-30 research-layout is-centered"> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border show" style="display: none;"> READ ALL <span class="f1r-icon icon-14_more_small orange vmiddle big"></span> </button> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border hide"> READ LESS <span class="f1r-icon icon-10_less_small orange vmiddle big"></span> </button> </div> </div> </div> <div class=clearfix></div> <div class="article-context no-divider"> <div class="article-abstract article-page-general-text-mobile research-layout generated-article-body"> <h2 class=main-title>Keywords</h2> <p class="u-mb--0 u-pb--2"> Vitiligo, melanocyte, oxidative stress, IFN-, Phototherapy, </p> </div> </div> <div class=article-information> <span class="info-separation padding-bottom"> <div id=corresponding-author-icon class="email-icon float-left"> <span class="f1r-icon icon-6_email orange"></span> <div id=corresponding-author-window class="margin-top-20 popup-window-wrapper is-hidden"> <div class="popup-window corresponding-authors-popup"> <div class=corresponding-author-container> <div class="popup-window-title small">Corresponding Author(s)</div> <div class=authors> Seth J. Orlow (<a href="mailto:seth.orlow@nyumc.org">seth.orlow@nyumc.org</a>) </div> </div> <div class="margin-top margin-bottom float-left"> <button id=close-popup-window class=general-white-orange-button>Close</button> </div> </div> </div> </div> <span class="icon-text float-left" data-test-id=box-corresponding-author> <b>Corresponding author:</b> Seth J. Orlow </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom competing-interests-display"> <span class=competing-interests-title>Competing interests:</span> In the past 12 months, Seth J. Orlow has served as a board member for Almirall and a consultant for Dermira, Provectus, and Unilever. Prashiela Manga and Nada Elbuluk declare that they have no competing interests. </span> <div class="info-separation padding-bottom grant-information-display"> <span class=grant-information-title>Grant information:</span> Research reported in this publication was supported in part by the National Institute of Arthritis and Musculoskeletal and Skin Diseases, part of the National Institutes of Health (NIH), under Award AR41880 (Seth J. Orlow). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. <br/> <i>The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</i> </div> <span class="f1r-article-desk info-separation padding-bottom"> <span class="copywrite-icon float-left"> <span class="f1r-icon icon-100_open_access"></span> </span> <span class="icon-text float-left" data-test-id=box-copyright-text> <b>Copyright:</b>&nbsp;  2016 Manga P <em>et al</em>. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom" data-test-id=box-how-to-cite> <b>How to cite:</b> <span class="article-title-and-info in-article-box"> Manga P, Elbuluk N and Orlow SJ. Recent advances in understanding vitiligo [version 1; peer review: 3 approved]</span>. <i>F1000Research</i> 2016, <b>5</b>(F1000 Faculty Rev):2234 (<a href="https://doi.org/10.12688/f1000research.8976.1" target=_blank>https://doi.org/10.12688/f1000research.8976.1</a>) </span> <span class=info-separation data-test-id=box-first-published><b>First published:</b> 06 Sep 2016, <b>5</b>(F1000 Faculty Rev):2234 (<a href="https://doi.org/10.12688/f1000research.8976.1" target=_blank>https://doi.org/10.12688/f1000research.8976.1</a>)</span> <span class=info-separation data-test-id=box-latest-published><b>Latest published:</b> 06 Sep 2016, <b>5</b>(F1000 Faculty Rev):2234 (<a href="https://doi.org/10.12688/f1000research.8976.1" target=_blank>https://doi.org/10.12688/f1000research.8976.1</a>)</span> </div> <div class=clearfix></div> <div id=article-context class=article-context> <div id=article1-body class=generated-article-body><h2 class=main-title id=d12294e191>Introduction</h2><p class="" id=d12294e194>Vitiligo affects about 1% of people worldwide and is phenotypically characterized by acquired depigmented patches of skin from which melanocytes (pigment-producing cells) have been lost<sup><a href="#ref-1">1</a></sup>. The most common type is non-segmental generalized vitiligo (hereafter referred to as vitiligo), which presents with widely distributed, usually symmetric, and progressive lesions. Vitiligo has a pronounced impact on the physical and mental health of patients, including loss of skin photoprotection, compromised cutaneous immunity, and an appreciable reduction in quality of life that is directly correlated with the early age of onset (typically in the first two decades of life)<sup><a href="#ref-2">2</a>,<a href="#ref-3">3</a></sup>.</p><p class="" id=d12294e208>Recent studies have begun to reveal the pathophysiology of vitiligo. A trigger event is thought to instigate stress responses in the skin that elicit an autoimmune response in genetically susceptible individuals that ultimately targets the melanocytes known to have an inherited fragility, predisposing individuals to develop vitiligo<sup><a href="#ref-4">4</a></sup>. The most significant progress in our understanding of disease etiology has been made on three fronts: characterizing the stress responses activated by vitiligo triggers, delineating the autoimmune components that cause disease progression, and identifying susceptibility genes. There are currently no treatments for vitiligo that effectively promote complete repigmentation with long-lasting effects while preventing recurrence. Total depigmentation therapy using monobenzone (for severe cases) is currently the only treatment approved by the US Food and Drug Administration (FDA) for vitiligo; novel approaches to prevent further loss and promote repigmentation are being investigated and may yield effective, long-lasting therapies. These efforts are supported by global collaborations that have drawn up consensus guidelines for disease classification<sup><a href="#ref-5">5</a></sup>, categorizing severity<sup><a href="#ref-6">6</a></sup>, and outcome measures that are also useful for clinical studies<sup><a href="#ref-7">7</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d12294e230>Stress responses in vitiligo</h2><p class="" id=d12294e233>The onset of vitiligo can be instigated by various triggers, including sunburn and exposure to phenolic chemicals; however, the trigger is not known in most cases. The triggers are all thought to induce oxidative stress in melanocytes<sup><a href="#ref-8">8</a></sup>. Individuals with vitiligo have been reported to have compromised antioxidant responses<sup><a href="#ref-9">9</a></sup>, with enzymes such as superoxide dismutase (SOD) present at higher-than-expected levels in tissue from perilesional areas and in sera<sup><a href="#ref-10">10</a></sup>. The key role of antioxidants in vitiligo has been suggested by a candidate gene association study, which found a significant association between single nucleotide polymorphism (SNP) rs3565214 within <i>NRF2</i> and vitiligo in the Chinese population<sup><a href="#ref-11">11</a></sup>.</p><p class="" id=d12294e255>There are multiple mechanisms through which excessive melanocyte oxidative stress can translate to an autoimmune reaction. For example, the antioxidant SOD has been linked to vitiligo, with increased expression in tissues from patients, and genetic linkage of isoforms 2 and 3 with increased susceptibility<sup><a href="#ref-12">12</a></sup>. The antioxidant response also promotes the expression of inducible heat shock protein 70 (iHSP70), which can serve multiple roles in the cellular stress response, including targeting the antioxidant SOD-2 to mitochondria<sup><a href="#ref-13">13</a></sup>.</p><p class="" id=d12294e266>Oxidative stress can also lead to increased iHSP70 secretion, which has been documented in vitiligo melanocytes<sup><a href="#ref-14">14</a></sup> and may provide a novel therapeutic target, since overexpression of iHSP70 in the skin has been shown to cause melanocyte loss in mice<sup><a href="#ref-15">15</a></sup>. Gene gun vaccination of mutant HSP70 before depigmentation in a vitiligo mouse model (mice expressing Pmel-1/gp100-reactive T cell receptor, resulting in melanocyte loss) prevented vitiligo, while depigmentation was reversed in a second model (mice expressing a tyrosinase-reactive T cell receptor, resulting in melanocyte loss) undergoing rapid pigment loss<sup><a href="#ref-14">14</a></sup>.</p><p class="" id=d12294e281>Melanocytes cultured from vitiligo patient skin samples were found to demonstrate changes in signal-transduction pathways such as mitogen-activated protein kinase hyperactivation and increased sensitivity to apoptosis inducers, which may be the result of sustained but sublethal oxidative stress. These melanocytes also expressed high levels of cytokines including interleukin-6 (IL-6), matrix metalloproteinase-3, and insulin-like growth factor-binding protein-3 and -7<sup><a href="#ref-16">16</a></sup>. Picardo <i>et al</i>.<sup><a href="#ref-17">17</a></sup> suggest that this constitutes a senescence phenotype characterized by the secretion of cytokines that provoke an autoimmune response similar to that seen in neurodegenerative disease.</p><p class="" id=d12294e296>Oxidative stress extends to the endoplasmic reticulum (ER), which is frequently dilated in perilesional melanocytes from patients with vitiligo<sup><a href="#ref-18">18</a></sup>. The ER is a sensor of cellular stress and the site of protein maturation, which requires a regulated environment to facilitate the chemical bond formation required for secondary and tertiary protein structure. Disruption of the ER redox balance results in the accumulation of misfolded proteins, which in turn activates the unfolded protein response (UPR)<sup><a href="#ref-19">19</a></sup>. The UPR ameliorates ER stress by signaling a transient halt in global protein synthesis, increasing the expression of chaperones that facilitate protein folding, and increasing the degradation of misfolded proteins; however, sustained activation results in apoptosis<sup><a href="#ref-20">20</a></sup>. Melanocytes can, however, adapt to continual UPR activity and evade UPR-induced death<sup><a href="#ref-21">21</a>,<a href="#ref-22">22</a></sup>. Chemical agents that trigger vitiligo, such as phenolics (4-tertiary-butylphenol and monobenzylether of hydroquinone), induce oxidative stress and promote UPR activation<sup><a href="#ref-23">23</a></sup>. UPR-induced expression of cytokines, such as IL-6 and IL-8, can attract immune components to the skin. The UPR may thus be the link between a trigger event and the initiation of an autoimmune response that results in vitiligo progression. Interestingly, the UPR also contributes to the activation of the immune response<sup><a href="#ref-24">24</a></sup> and plays a role in autoimmune disorders<sup><a href="#ref-25">25</a></sup> such as type I diabetes<sup><a href="#ref-26">26</a></sup> and neurodegenerative disorders<sup><a href="#ref-27">27</a></sup>. Genome-wide linkage analysis followed by a sequencing study in a Chinese population with vitiligo identified X-box binding protein 1 (<i>XBP1</i>)<sup><a href="#ref-28">28</a>,<a href="#ref-29">29</a></sup>, which was then confirmed in a vitiligo Caucasian cohort<sup><a href="#ref-30">30</a></sup>; this gene encodes a transcription factor that mediates UPR activation<sup><a href="#ref-31">31</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d12294e361>The autoimmune component</h2><p class="" id=d12294e364>Autoimmunity has long been suspected to feature significantly in the pathogenesis of vitiligo, and multiple studies published in the past few years increasingly shed light on the role of the immune system in vitiligo. CD8<sup>+</sup> T cells specific to, and capable of killing, melanocytes are increased in the blood of those with vitiligo compared to healthy controls, and numbers correlate with disease activity. Using an engineered mouse model of vitiligo, Harris and co-workers had previously found that interferon (IFN)- played a central role in the spread of vitiligo lesions<sup><a href="#ref-32">32</a></sup>. Specifically, they showed that IFN- caused an increase in the expression of CXCL10, a chemokine which regulates the invasion of epidermal and follicular tissues by CD8<sup>+</sup> T cells. IFN- was also identified as part of a signature cytokine profile in an avian model of vitiligo. The Smyth line (SL) of chickens develops a spontaneous, depigmentation disorder that shares several key clinical and pathologic features with human vitiligo. For example, melanocytes that pigment the feathers are lost in an autoimmune-driven process. As the disease progresses, there is an increase in the expression of IFN-<sup><a href="#ref-33">33</a></sup>. Recently, however, a study by Yang <i>et al</i>. suggested that IFN- could play an even more direct role in vitiligo pathogenesis by demonstrating that the IFN- derived from cytotoxic T cells could itself cause apoptosis in melanocytes<sup><a href="#ref-34">34</a></sup>. An accompanying editorial by Harris clearly puts Yangs groups results into the larger context<sup><a href="#ref-35">35</a></sup>.</p><p class="" id=d12294e393>IL-17 and T helper type 17 (Th17) cells, which elaborate this cytokine, have been increasingly recognized to play an important role in autoimmunity. The potential role of Th17 in vitiligo has recently been reviewed comprehensively by Singh and colleagues<sup><a href="#ref-36">36</a></sup>. They discuss recent studies in which blood, tissue, and cellular levels of IL-17 have been found to be elevated in vitiligo. Positive correlations between levels of IL-17 and disease extent and activity have also been found. A recent example that illustrates this is the work of Zhou <i>et al</i>.<sup><a href="#ref-37">37</a></sup>. They found that levels of Th17 cells (as well as the cytokines transforming growth factor [TGF]- and IL-21, which matched the findings in the SL avian model, where the expression of IL-21<sup><a href="#ref-33">33</a></sup> and its receptor, IL-21R, increased as the disease progressed<sup><a href="#ref-38">38</a></sup>) correlated with disease activity in generalized vitiligo. Singh <i>et al</i>. also discussed how treatments that improve vitiligo, such as ultraviolet B (UVB) phototherapy, may also modulate IL-17 levels. These findings are particularly exciting in view of the increasing availability of biologic therapeutics that target the IL-17 axis.</p><p class="" id=d12294e419>While the ability to inhibit IL-17 in the clinical sphere is relatively new, inhibitors of TNF- have been available for over a decade. Some (but not all) studies previously published have shown an increase in tumor necrosis factor (TNF)- associated with vitiligo. Webb <i>et al</i>.<sup><a href="#ref-39">39</a></sup> observed that TNF- inhibition was associated with the blockade of progression in three vitiligo patients and pointed out that this effect might have been missed previously because past studies focused on the ability of TNF- blockade to promote repigmentation, a very different endpoint. They also noted the paradoxical onset of vitiligo reported in some patients with other autoimmune diseases treated with TNF- inhibitors. This phenomenon has also been observed in psoriasis, where TNF- inhibitors ushered in the modern era of efficacious psoriasis therapy, yet sometimes psoriasis can develop <i>de novo</i> in patients with another autoimmune disease like rheumatoid arthritis or inflammatory bowel disease treated with a TNF- inhibitor.</p><p class="" id=d12294e432>The increased levels of IL-21 noted above by Zhou <i>et al</i>.<sup><a href="#ref-37">37</a></sup> raise the question of the involvement of a newly recognized subset of T cells, called follicular helper T (Tfh) cells, in vitiligo. Tfh cells can be distinguished from Th17 cells by both their production of IL-21 and their ability to home to B cell areas in secondary lymphoid tissue. Tfh cells and IL-21 are believed to play a central role in B cell activation but are increasingly recognized as possible players in the immune dysregulation that typifies autoimmunity. Furthermore, IL-21 has been shown to be critical in the pathogenesis of murine autoimmune diabetes<sup><a href="#ref-40">40</a></sup> and promotes an increase in CD8+ T cells<sup><a href="#ref-41">41</a></sup> and mediates prolonging of their cytotoxic responses<sup><a href="#ref-42">42</a></sup>.</p><p class="" id=d12294e455>The class I and class II major histocompatibility loci located on chromosome 6p21.3 have been associated with a variety of autoimmune diseases, including vitiligo. Some such associations could point to a preferential presentation by cells of certain antigensfor example, melanocyte-specific antigens like tyrosinaseto the immune system. Recently, through a genome-wide association study of 2,853 Caucasian vitiligo patients<sup><a href="#ref-43">43</a></sup>, Spritz, Dinarello, and colleagues found three SNPs located within a predicted super-enhancer in an intergenic region between the HLA-DRB1 and HLA-DQA1 loci. The super-enhancer correlated with increased expression of both major histocompatibility complex (MHC) class II proteins on monocytes from normal volunteers homozygous for the high-risk haplotype. They found that upon stimulation of monocytes with microbe-derived products, the production of both IFN- and IL-1 was 2.5- and 5-fold higher, respectively, in those with the high-risk haplotype than it was in those homozygous for the low-risk haplotype, thereby providing a potential link between the level of MHC class II expression and the elaboration of cytokines that could provoke or perpetuate an autoimmune response. Spritz and colleagues also identified a haplotype at the MHC class I locus that is associated with vitiligo susceptibility. The haplotype spans a region that includes a transcriptional regulator downstream of the <i>HLA-A</i> gene, and carriers of the vitiligo-associated haplotype were found to express higher levels of HLA-A RNA transcript compared to carriers of the non-vitiligo-associated haplotypes<sup><a href="#ref-44">44</a></sup>. Vitiligo susceptibility is also associated with the HLA-A *02:01:01:01 allele<sup><a href="#ref-45">45</a></sup>, which encodes HLA-A2 and can present melanocyte protein-derived autoantigens. When the vitiligo-associated risk haplotype/alleles are present in combination, the regulatory region risk haplotype drives elevated expression of HLA-A2 and thus increased presentation of melanocyte-specific proteins that are readily recognized by cytotoxic T cells<sup><a href="#ref-44">44</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d12294e480>Advances in vitiligo treatments</h2><p class="" id=d12294e483>Therapeutic options available for stabilizing and repigmenting vitiligo have been modestly expanded in recent years, although only depigmentation therapy using monobenzone is approved by the FDA. Depigmentation therapy is reserved for the treatment of remaining normal skin in those with extensive vitiligo affecting the majority of ones body. Traditional therapies for repigmentation, including topical agents and phototherapy, remain mainstays of current treatment. Topical treatments include corticosteroids, calcineurin inhibitors, and vitamin D analogues<sup><a href="#ref-46">46</a><a href="#ref-49">49</a></sup>. Phototherapy treatments include narrowband UVB (NB-UVB) or psoralen and UVA (PUVA)<sup><a href="#ref-46">46</a><a href="#ref-49">49</a></sup>. NB-UVB, which consists of 311313 nm, can be given to the whole body using lamps or as a focused, targeted treatment using a 308 nm xenon-chloride monochromatic excimer light emitted through a laser or incoherent lamp<sup><a href="#ref-50">50</a><a href="#ref-52">52</a></sup>. More recently, studies have evaluated other types of phototherapy such as broadband UVB (280320 nm), psoralen combined with NB-UVB, UVA-1, and PUVA sol<sup><a href="#ref-53">53</a><a href="#ref-56">56</a></sup>. Newer studies of traditional treatments have compared the use of these treatments as monotherapies as well as evaluated the efficacy of combining treatments for a multimodal approach<sup><a href="#ref-57">57</a><a href="#ref-60">60</a></sup>. Several studies have found that phototherapy combined with topical creams yield faster and greater repigmentation than each treatment modality as a monotherapy<sup><a href="#ref-57">57</a>,<a href="#ref-59">59</a>,<a href="#ref-60">60</a></sup>. While the combination approach has led to successful repigmentation for many patients, there remain many individuals who have unsatisfactory results and for whom alternative treatment options are needed. Advances in vitiligo therapy have sought to investigate these alternative treatments, which include topical, oral, and procedural treatments that seek to target different pathways involved in the pathogenesis of vitiligo.</p><div class=section><a name=d12294e532 class=n-a></a><h3 class=section-title>Topical treatments</h3><p class="" id=d12294e537>Prostaglandin analogues traditionally used for glaucoma therapy have been found to induce hyperpigmentation through effects that lead to melanocyte proliferation<sup><a href="#ref-61">61</a></sup>. Several studies have evaluated the use of topical prostaglandin analogues for the treatment of localized vitiligo<sup><a href="#ref-61">61</a><a href="#ref-63">63</a></sup>. Two different studies evaluating the use of topical prostaglandin E2 on localized areas of vitiligo for 6 months resulted in moderate to complete repigmentation in the majority of patients<sup><a href="#ref-62">62</a>,<a href="#ref-63">63</a></sup>. Another study found that topical latanoprost was found to result in comparable results to NB-UVB and, when the two therapies were combined together, it led to greater repigmentation<sup><a href="#ref-64">64</a></sup>. Larger, randomized controlled trials and comparative studies with other treatment alternatives are needed to better determine the efficacy and safety of prostaglandin analogues for vitiligo repigmentation.</p></div><div class=section><a name=d12294e563 class=n-a></a><h3 class=section-title>Oral and systemic treatments</h3><p class="" id=d12294e568>Oral corticosteroids have often been used for short durations in rapidly spreading vitiligo; however, caution must be taken given the potential side effects of systemic steroids. Studies have sought to find lower strengths of steroids, which can still provide benefit in halting the progression of vitiligo. Kanwar <i>et al</i>. found that low-dose oral dexamethasone mini pulse therapy of 2.5 mg per day on two consecutive days of the week halted vitiligo in 91.8% of subjects in roughly 13 weeks<sup><a href="#ref-65">65</a></sup>.</p><p class="" id=d12294e578>Minocycline, a broad-spectrum antibiotic, has also been evaluated in vitiligo owing to its anti-inflammatory, antioxidant, and immunomodulatory properties<sup><a href="#ref-66">66</a><a href="#ref-68">68</a></sup>. Minocyclines ability to scavenge free radicals has been found to have a protective effect on melanocytes against H<sub>2</sub>O<sub>2</sub>-induced apoptosis<sup><a href="#ref-69">69</a></sup>. A clinical study in which vitiligo patients were given minocycline 100 mg once daily showed arrest of disease progression in 91% of patients<sup><a href="#ref-67">67</a></sup>. A randomized clinical trial compared treatment with 6 months of minocycline to oral mini pulse corticosteroids and found that the two treatments were comparable in stopping the progression of actively spreading vitiligo with minimal side effects in each group<sup><a href="#ref-68">68</a></sup>.</p><p class="" id=d12294e607>Oral statins, traditionally used to lower cholesterol, have also been evaluated in vitiligo treatment because of their immunomodulating and antioxidant properties. In addition to scavenging free radicals, statins lead to the downregulation of inflammatory cytokines including IL-6, IL-2, IFN-, and TNF-<sup><a href="#ref-70">70</a>,<a href="#ref-71">71</a></sup>. Regression of vitiligo was first reported in a case report of a man with vitiligo who was taking high-dose oral simvastatin for treatment of high cholesterol<sup><a href="#ref-72">72</a></sup>. Agarwal <i>et al</i>. found that in a mouse model of vitiligo, statins could prevent and reverse depigmentation of vitiligo by decreasing IFN- production and by stopping the influx and proliferation of cutaneous autoreactive CD8+ T cells<sup><a href="#ref-73">73</a></sup>.</p><p class="" id=d12294e628>Agents which are commonly used to treat rheumatologic diseases and psoriasis are also being studied in the treatment of autoimmune diseases including vitiligo. Janus kinase (JAK) inhibitors have been evaluated in several case reports, with potential therapeutic promise thought to be related to their interference with IFN- signaling<sup><a href="#ref-48">48</a>,<a href="#ref-49">49</a>,<a href="#ref-74">74</a>,<a href="#ref-75">75</a></sup>. Research has shown that IFN--induced expression of CXCL10 is critical for the progression and maintenance of depigmentation in vitiligo<sup><a href="#ref-76">76</a></sup>. In a recent case report, a patient with vitiligo was treated with tofacitinib, an oral JAK 1/3 inhibitor, for 5 months, and had significant repigmentation with no significant adverse effects<sup><a href="#ref-74">74</a></sup>. Ruxolitinib, another JAK inhibitor, was studied in a patient with alopecia areata and vitiligo and was found to lead to 51% facial repigmentation compared to 0.8% at baseline<sup><a href="#ref-75">75</a></sup>. However, 12 weeks after discontinuation of the drug, the patient had lost much of the pigment he had regained.</p><p class="" id=d12294e657>Oral vitamins and supplements have also gained increased interest in the treatment of vitiligo owing to their antioxidant properties. L-phenylalanine, khellin, polypodium leucotomos, <i>Ginkgo biloba</i>, B12, folic acid, vitamins C and E, alpha lipoic acid, and zinc have all been studied either as monotherapies or in combination with other treatments with varying efficacy in improving vitiligo repigmentation<sup><a href="#ref-3">3</a>,<a href="#ref-77">77</a><a href="#ref-84">84</a></sup>. Though several of these treatments are promising, the majority of these studies have been done in a small number of patients and many without controls. Larger randomized controlled trials are needed to make more definitive treatment recommendations and to better understand how these agents can reverse depigmentation.</p><p class="" id=d12294e673>Afamelanotide, a longer-acting synthetic analogue of alpha-melanocyte-stimulating hormone, has also shown promise in early clinical studies<sup><a href="#ref-59">59</a>,<a href="#ref-60">60</a>,<a href="#ref-85">85</a>,<a href="#ref-86">86</a></sup>. By binding to the melanocortin-1 receptor, afamelanotide may combat melanocortin system defects in vitiligo patients by stimulating melanocyte proliferation and melanogenesis. An early phase clinical trial found that when patients were given an implant of 16 mg of afamelanotide and then had additional NB-UVB treatment, the combination yielded faster and more extensive repigmentation of facial and upper extremity vitiligo lesions than did patients who received only NB-UVB<sup><a href="#ref-86">86</a>,<a href="#ref-87">87</a></sup>. Adverse effects of this treatment include nausea, fatigue, abdominal pain, and hyperpigmentation.</p></div><div class=section><a name=d12294e697 class=n-a></a><h3 class=section-title>Procedural treatments</h3><p class="" id=d12294e702>Several procedural treatments using laser and surgical techniques may also provide hope for patients with stable vitiligo who have not repigmented with traditional therapies. Erbium laser-assisted dermabrasion and fractional CO<sub>2</sub> lasers have been used on vitiligo patients followed by NB-UVB and have been found to result in superior repigmentation compared with the use of NB-UVB alone<sup><a href="#ref-88">88</a>,<a href="#ref-89">89</a></sup>. However, the pain, scarring, and healing time that can be associated with ablative laser therapy may preclude this from becoming a more mainstream treatment option.</p><p class="" id=d12294e715>Additional surgical options for vitiligo treatment include autologous punch and suction blister grafts, split thickness grafts, needling, and non-cultured epidermal cell suspension also known as melanocyte keratinocyte transplantation (MKTP)<sup><a href="#ref-90">90</a><a href="#ref-95">95</a></sup>. The latter technique involves the application of an autologous cell mixture to an abraded recipient site. This is often followed by continued treatment with phototherapy. Improvements to this technique have made it an effective and well-tolerated procedure with high repigmentation rates<sup><a href="#ref-96">96</a>,<a href="#ref-97">97</a></sup>.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d12294e736>Conclusion</h2><p class="" id=d12294e739>Current medical and surgical therapies for vitiligo, particularly when used in combination, have shown some success in the stabilization and repigmentation of vitiligo. New therapies are on the horizon, and the future for vitiligo is promising. In addition, international collaborations to establish common outcome criteria will support these efforts<sup><a href="#ref-7">7</a></sup>. Continued research into the pathogenesis of this complex and multifactorial disease will help provide further insight into disease targets and how to best approach treatment.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d12294e750>Abbreviations</h2><p class="" id=d12294e753>ER, endoplasmic reticulum; FDA, US Food and Drug Administration; IFN, interferon; iHSP70, inducible heat shock protein 70; IL, interleukin; JAK, Janus Kinase; MHC, major histocompatibility complex; NB-UVB, narrowband UVB; NRF2, nuclear factor erythroid 2-related factor 2; PUVA, psoralen and ultraviolet A; SL, Smyth line; SNP, single nucleotide polymorphism; SOD, superoxide dismutase; Tfh, follicular T helper; TH17, T helper type 17; TNF, tumor necrosis factor; UPR, unfolded protein response; UVB, ultraviolet B.</p></div><div id=article1-back class=generated-article-footer><div class=back-section><a name=d12294e1 class=n-a></a><h2 class=main-title id=d12574>Competing interests</h2><p class=metadata-entry><a name=d12294e105 class=n-a></a><p id=d12294e107> In the past 12 months, Seth J. Orlow has served as a board member for Almirall and a consultant for Dermira, Provectus, and Unilever. Prashiela Manga and Nada Elbuluk declare that they have no competing interests.</p></p></div><div class=back-section><a name=d12294e1 class=n-a></a><h2 class=main-title id=d12576>Grant information</h2><p>Research reported in this publication was supported in part by the National Institute of Arthritis and Musculoskeletal and Skin Diseases, part of the National Institutes of Health (NIH), under Award AR41880 (Seth J. Orlow). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.</p><p> <i>The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</i> </p></div><div class=back-section><a name=d12294e760 class=n-a></a><span class="research-layout prime-recommended-wrapper reference-heading"><span class="f1r-icon icon-79_faculty_recommended_badge red vmiddle default-cursor"></span><span class="prime-red big">F1000 recommended</span></span><h2 class=main-title id=d12889>References</h2><div class="section ref-list"><a name=d12294e760 class=n-a></a><ul><li><a name=ref-1 class=n-a></a><span class=label>1. </span>&nbsp;<span class=citation><a name=d12294e767 class=n-a></a>Le Poole IC, Das PK, van den Wijngaard RM, <i> et al.</i>: Review of the etiopathomechanism of vitiligo: a convergence theory. <i>Exp Dermatol.</i> 1993; <b>2</b>(4): 14553. <a target=xrefwindow id=d12294e778 href="http://www.ncbi.nlm.nih.gov/pubmed/8162332">PubMed Abstract </a> | <a target=xrefwindow id=d12294e781 href="http://dx.doi.org/10.1111/j.1600-0625.1993.tb00023.x">Publisher Full Text </a></span></li><li><a name=ref-2 class=n-a></a><span class=label>2. </span>&nbsp;<span class=citation><a name=d12294e790 class=n-a></a>Le Poole C, Boissy RE: Vitiligo. <i>Semin Cutan Med Surg.</i> 1997; <b>16</b>(1): 314. <a target=xrefwindow id=d12294e798 href="http://www.ncbi.nlm.nih.gov/pubmed/9125760">PubMed Abstract </a></span></li><li><a name=ref-3 class=n-a></a><span class=label>3. </span>&nbsp;<span class=citation><a name=d12294e807 class=n-a></a>Parsad D, Dogra S, Kanwar AJ: Quality of life in patients with vitiligo. <i>Health Qual Life Outcomes.</i> 2003; <b>1</b>: 58. <a target=xrefwindow id=d12294e815 href="http://www.ncbi.nlm.nih.gov/pubmed/14613564">PubMed Abstract </a> | <a target=xrefwindow id=d12294e818 href="http://dx.doi.org/10.1186/1477-7525-1-58">Publisher Full Text </a> | <a target=xrefwindow id=d12294e821 href="http://www.ncbi.nlm.nih.gov/pmc/articles/269995">Free Full Text </a></span></li><li><a name=ref-4 class=n-a></a><span class=label>4. </span>&nbsp;<span class=citation><a name=d12294e830 class=n-a></a>Boissy RE, Manga P: On the etiology of contact/occupational vitiligo. <i>Pigment Cell Res.</i> 2004; <b>17</b>(3): 20814. <a target=xrefwindow id=d12294e838 href="http://www.ncbi.nlm.nih.gov/pubmed/15140065">PubMed Abstract </a> | <a target=xrefwindow id=d12294e841 href="http://dx.doi.org/10.1111/j.1600-0749.2004.00130.x">Publisher Full Text </a></span></li><li><a name=ref-5 class=n-a></a><span class=label>5. </span>&nbsp;<span class=citation><a name=d12294e850 class=n-a></a>Ezzedine K, Lim HW, Suzuki T, <i> et al.</i>: Revised classification/nomenclature of vitiligo and related issues: the Vitiligo Global Issues Consensus Conference. <i>Pigment Cell Melanoma Res.</i> 2012; <b>25</b>(3): E113. <a target=xrefwindow id=d12294e861 href="http://www.ncbi.nlm.nih.gov/pubmed/22417114">PubMed Abstract </a> | <a target=xrefwindow id=d12294e864 href="http://dx.doi.org/10.1111/j.1755-148X.2012.00997.x">Publisher Full Text </a> | <a target=xrefwindow id=d12294e868 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3511780">Free Full Text </a></span></li><li><a name=ref-6 class=n-a></a><span class=label>6. </span>&nbsp;<span class=citation><a name=d12294e878 class=n-a></a>van Geel N, Lommerts J, Bekkenk M, <i> et al.</i>: Development and Validation of the Vitiligo Extent Score (VES): an International Collaborative Initiative. <i>J Invest Dermatol.</i> 2016; <b>136</b>(5): 97884. <a target=xrefwindow id=d12294e889 href="http://www.ncbi.nlm.nih.gov/pubmed/26827762">PubMed Abstract </a> | <a target=xrefwindow id=d12294e892 href="http://dx.doi.org/10.1016/j.jid.2015.12.040">Publisher Full Text </a></span></li><li><a name=ref-7 class=n-a></a><span class=label>7. </span>&nbsp;<span class=citation><a name=d12294e901 class=n-a></a>Eleftheriadou V, Thomas K, van Geel N, <i> et al.</i>: Developing core outcome set for vitiligo clinical trials: international e-Delphi consensus. <i>Pigment Cell Melanoma Res.</i> 2015; <b>28</b>(3): 3639. <a target=xrefwindow id=d12294e912 href="http://www.ncbi.nlm.nih.gov/pubmed/25645179">PubMed Abstract </a> | <a target=xrefwindow id=d12294e915 href="http://dx.doi.org/10.1111/pcmr.12354">Publisher Full Text </a></span></li><li><a name=ref-8 class=n-a></a><span class=label>8. </span>&nbsp;<span class=citation><a name=d12294e924 class=n-a></a>Picardo M, Bastonini E: A New View of Vitiligo: Looking at Normal-Appearing Skin. <i>J Invest Dermatol.</i> 2015; <b>135</b>(7): 17134. <a target=xrefwindow id=d12294e932 href="http://www.ncbi.nlm.nih.gov/pubmed/26066890">PubMed Abstract </a> | <a target=xrefwindow id=d12294e935 href="http://dx.doi.org/10.1038/jid.2015.92">Publisher Full Text </a></span></li><li><a name=ref-9 class=n-a></a><span class=label>9. </span>&nbsp;<span class=citation><a name=d12294e944 class=n-a></a>Yildirim M, Baysal V, Inaloz HS, <i> et al.</i>: The role of oxidants and antioxidants in generalized vitiligo. <i>J Dermatol.</i> 2003; <b>30</b>(2): 1048. <a target=xrefwindow id=d12294e955 href="http://www.ncbi.nlm.nih.gov/pubmed/12692376">PubMed Abstract </a> | <a target=xrefwindow id=d12294e958 href="http://dx.doi.org/10.1111/j.1346-8138.2003.tb00356.x">Publisher Full Text </a></span></li><li><a name=ref-10 class=n-a></a><span class=label>10. </span>&nbsp;<span class=citation><a name=d12294e967 class=n-a></a>Dammak I, Boudaya S, Ben Abdallah F, <i> et al.</i>: Antioxidant enzymes and lipid peroxidation at the tissue level in patients with stable and active vitiligo. <i>Int J Dermatol.</i> 2009; <b>48</b>(5): 47680. <a target=xrefwindow id=d12294e978 href="http://www.ncbi.nlm.nih.gov/pubmed/19416376">PubMed Abstract </a> | <a target=xrefwindow id=d12294e981 href="http://dx.doi.org/10.1111/j.1365-4632.2009.03998.x">Publisher Full Text </a></span></li><li><a name=ref-11 class=n-a></a><span class=label>11. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/726379327"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12294e990 class=n-a></a>Song P, Li K, Liu L, <i> et al.</i>: Genetic polymorphism of the <i>Nrf2</i> promoter region is associated with vitiligo risk in Han Chinese populations. <i>J Cell Mol Med.</i> 2016; 111. <a target=xrefwindow id=d12294e1001 href="http://www.ncbi.nlm.nih.gov/pubmed/27222475">PubMed Abstract </a> | <a target=xrefwindow id=d12294e1004 href="http://dx.doi.org/10.1111/jcmm.12874">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/726379327">F1000 Recommendation</a></span></li><li><a name=ref-12 class=n-a></a><span class=label>12. </span>&nbsp;<span class=citation><a name=d12294e1018 class=n-a></a>Laddha NC, Dwivedi M, Mansuri MS, <i> et al.</i>: Vitiligo: interplay between oxidative stress and immune system. <i>Exp Dermatol.</i> 2013; <b>22</b>(4): 24550. <a target=xrefwindow id=d12294e1029 href="http://www.ncbi.nlm.nih.gov/pubmed/23425123">PubMed Abstract </a> | <a target=xrefwindow id=d12294e1032 href="http://dx.doi.org/10.1111/exd.12103">Publisher Full Text </a></span></li><li><a name=ref-13 class=n-a></a><span class=label>13. </span>&nbsp;<span class=citation><a name=d12294e1041 class=n-a></a>Afolayan AJ, Teng RJ, Eis A, <i> et al.</i>: Inducible HSP70 regulates superoxide dismutase-2 and mitochondrial oxidative stress in the endothelial cells from developing lungs. <i>Am J Physiol Lung Cell Mol Physiol.</i> 2014; <b>306</b>(4): L35160. <a target=xrefwindow id=d12294e1052 href="http://www.ncbi.nlm.nih.gov/pubmed/24375796">PubMed Abstract </a> | <a target=xrefwindow id=d12294e1055 href="http://dx.doi.org/10.1152/ajplung.00264.2013">Publisher Full Text </a> | <a target=xrefwindow id=d12294e1059 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3920226">Free Full Text </a></span></li><li><a name=ref-14 class=n-a></a><span class=label>14. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/718215034"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12294e1068 class=n-a></a>Mosenson JA, Flood K, Klarquist J, <i> et al.</i>: Preferential secretion of inducible HSP70 by vitiligo melanocytes under stress. <i>Pigment Cell Melanoma Res.</i> 2014; <b>27</b>(2): 20920. <a target=xrefwindow id=d12294e1079 href="http://www.ncbi.nlm.nih.gov/pubmed/24354861">PubMed Abstract </a> | <a target=xrefwindow id=d12294e1082 href="http://dx.doi.org/10.1111/pcmr.12208">Publisher Full Text </a> | <a target=xrefwindow id=d12294e1086 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3947476">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/718215034">F1000 Recommendation</a></span></li><li><a name=ref-15 class=n-a></a><span class=label>15. </span>&nbsp;<span class=citation><a name=d12294e1099 class=n-a></a>Denman CJ, McCracken J, Hariharan V, <i> et al.</i>: HSP70i accelerates depigmentation in a mouse model of autoimmune vitiligo. <i>J Invest Dermatol.</i> 2008; <b>128</b>(8): 20418. <a target=xrefwindow id=d12294e1110 href="http://www.ncbi.nlm.nih.gov/pubmed/18337834">PubMed Abstract </a> | <a target=xrefwindow id=d12294e1113 href="http://dx.doi.org/10.1038/jid.2008.45">Publisher Full Text </a> | <a target=xrefwindow id=d12294e1117 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3778919">Free Full Text </a></span></li><li><a name=ref-16 class=n-a></a><span class=label>16. </span>&nbsp;<span class=citation><a name=d12294e1126 class=n-a></a>Bellei B, Pitisci A, Ottaviani M, <i> et al.</i>: Vitiligo: a possible model of degenerative diseases. <i>PLoS One.</i> 2013; <b>8</b>(3): e59782. <a target=xrefwindow id=d12294e1137 href="http://www.ncbi.nlm.nih.gov/pubmed/23555779">PubMed Abstract </a> | <a target=xrefwindow id=d12294e1140 href="http://dx.doi.org/10.1371/journal.pone.0059782">Publisher Full Text </a> | <a target=xrefwindow id=d12294e1144 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3608562">Free Full Text </a></span></li><li><a name=ref-17 class=n-a></a><span class=label>17. </span>&nbsp;<span class=citation><a name=d12294e1153 class=n-a></a>Picardo M, Dell'Anna ML, Ezzedine K, <i> et al.</i>: Vitiligo. <i>Nat Rev Dis Primers.</i> 2015; <b>1</b>: 15011. <a target=xrefwindow id=d12294e1164 href="http://www.ncbi.nlm.nih.gov/pubmed/27189851">PubMed Abstract </a> | <a target=xrefwindow id=d12294e1167 href="http://dx.doi.org/10.1038/nrdp.2015.11">Publisher Full Text </a></span></li><li><a name=ref-18 class=n-a></a><span class=label>18. </span>&nbsp;<span class=citation><a name=d12294e1177 class=n-a></a>Boissy RE, Liu YY, Medrano EE, <i> et al.</i>: Structural aberration of the rough endoplasmic reticulum and melanosome compartmentalization in long-term cultures of melanocytes from vitiligo patients. <i>J Invest Dermatol.</i> 1991; <b>97</b>(3): 395404. <a target=xrefwindow id=d12294e1188 href="http://www.ncbi.nlm.nih.gov/pubmed/1875040">PubMed Abstract </a></span></li><li><a name=ref-19 class=n-a></a><span class=label>19. </span>&nbsp;<span class=citation><a name=d12294e1197 class=n-a></a>Eletto D, Chevet E, Argon Y, <i> et al.</i>: Redox controls UPR to control redox. <i>J Cell Sci.</i> 2014; <b>127</b>(Pt 17): 364958. <a target=xrefwindow id=d12294e1208 href="http://www.ncbi.nlm.nih.gov/pubmed/25107370">PubMed Abstract </a> | <a target=xrefwindow id=d12294e1211 href="http://dx.doi.org/10.1242/jcs.153643">Publisher Full Text </a></span></li><li><a name=ref-20 class=n-a></a><span class=label>20. </span>&nbsp;<span class=citation><a name=d12294e1220 class=n-a></a>Malhotra JD, Kaufman RJ: The endoplasmic reticulum and the unfolded protein response. <i>Semin Cell Dev Biol.</i> 2007; <b>18</b>(6): 71631. <a target=xrefwindow id=d12294e1228 href="http://www.ncbi.nlm.nih.gov/pubmed/18023214">PubMed Abstract </a> | <a target=xrefwindow id=d12294e1231 href="http://dx.doi.org/10.1016/j.semcdb.2007.09.003">Publisher Full Text </a> | <a target=xrefwindow id=d12294e1234 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2706143">Free Full Text </a></span></li><li><a name=ref-21 class=n-a></a><span class=label>21. </span>&nbsp;<span class=citation><a name=d12294e1243 class=n-a></a>Manga P, Bis S, Knoll K, <i> et al.</i>: The unfolded protein response in melanocytes: activation in response to chemical stressors of the endoplasmic reticulum and tyrosinase misfolding. <i>Pigment Cell Melanoma Res.</i> 2010; <b>23</b>(5): 62734. <a target=xrefwindow id=d12294e1254 href="http://www.ncbi.nlm.nih.gov/pubmed/20444203">PubMed Abstract </a> | <a target=xrefwindow id=d12294e1257 href="http://dx.doi.org/10.1111/j.1755-148X.2010.00718.x">Publisher Full Text </a> | <a target=xrefwindow id=d12294e1261 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2939946">Free Full Text </a></span></li><li><a name=ref-22 class=n-a></a><span class=label>22. </span>&nbsp;<span class=citation><a name=d12294e1270 class=n-a></a>Cheng T, Orlow SJ, Manga P: Loss of <i>Oca2</i> disrupts the unfolded protein response and increases resistance to endoplasmic reticulum stress in melanocytes. <i>Pigment Cell Melanoma Res.</i> 2013; <b>26</b>(6): 82634. <a target=xrefwindow id=d12294e1281 href="http://www.ncbi.nlm.nih.gov/pubmed/23962237">PubMed Abstract </a> | <a target=xrefwindow id=d12294e1284 href="http://dx.doi.org/10.1111/pcmr.12158">Publisher Full Text </a> | <a target=xrefwindow id=d12294e1288 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3832131">Free Full Text </a></span></li><li><a name=ref-23 class=n-a></a><span class=label>23. </span>&nbsp;<span class=citation><a name=d12294e1297 class=n-a></a>Toosi S, Orlow SJ, Manga P: Vitiligo-inducing phenols activate the unfolded protein response in melanocytes resulting in upregulation of IL6 and IL8. <i>J Invest Dermatol.</i> 2012; <b>132</b>(11): 26019. <a target=xrefwindow id=d12294e1305 href="http://www.ncbi.nlm.nih.gov/pubmed/22696056">PubMed Abstract </a> | <a target=xrefwindow id=d12294e1308 href="http://dx.doi.org/10.1038/jid.2012.181">Publisher Full Text </a> | <a target=xrefwindow id=d12294e1311 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3443495">Free Full Text </a></span></li><li><a name=ref-24 class=n-a></a><span class=label>24. </span>&nbsp;<span class=citation><a name=d12294e1321 class=n-a></a>Bettigole SE, Glimcher LH: Endoplasmic reticulum stress in immunity. <i>Annu Rev Immunol.</i> 2015; <b>33</b>: 10738. <a target=xrefwindow id=d12294e1329 href="http://www.ncbi.nlm.nih.gov/pubmed/25493331">PubMed Abstract </a> | <a target=xrefwindow id=d12294e1332 href="http://dx.doi.org/10.1146/annurev-immunol-032414-112116">Publisher Full Text </a></span></li><li><a name=ref-25 class=n-a></a><span class=label>25. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/13864969"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12294e1341 class=n-a></a>Todd DJ, Lee AH, Glimcher LH: The endoplasmic reticulum stress response in immunity and autoimmunity. <i>Nat Rev Immunol.</i> 2008; <b>8</b>(9): 66374. <a target=xrefwindow id=d12294e1349 href="http://www.ncbi.nlm.nih.gov/pubmed/18670423">PubMed Abstract </a> | <a target=xrefwindow id=d12294e1352 href="http://dx.doi.org/10.1038/nri2359">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/13864969">F1000 Recommendation</a></span></li><li><a name=ref-26 class=n-a></a><span class=label>26. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/1047341"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12294e1365 class=n-a></a>Lipson KL, Fonseca SG, Ishigaki S, <i> et al.</i>: Regulation of insulin biosynthesis in pancreatic beta cells by an endoplasmic reticulum-resident protein kinase IRE1. <i>Cell Metab.</i> 2006; <b>4</b>(3): 24554. <a target=xrefwindow id=d12294e1376 href="http://www.ncbi.nlm.nih.gov/pubmed/16950141">PubMed Abstract </a> | <a target=xrefwindow id=d12294e1379 href="http://dx.doi.org/10.1016/j.cmet.2006.07.007">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/1047341">F1000 Recommendation</a></span></li><li><a name=ref-27 class=n-a></a><span class=label>27. </span>&nbsp;<span class=citation><a name=d12294e1392 class=n-a></a>Matus S, Glimcher LH, Hetz C: Protein folding stress in neurodegenerative diseases: a glimpse into the ER. <i>Curr Opin Cell Biol.</i> 2011; <b>23</b>(2): 23952. <a target=xrefwindow id=d12294e1400 href="http://www.ncbi.nlm.nih.gov/pubmed/21288706">PubMed Abstract </a> | <a target=xrefwindow id=d12294e1403 href="http://dx.doi.org/10.1016/j.ceb.2011.01.003">Publisher Full Text </a></span></li><li><a name=ref-28 class=n-a></a><span class=label>28. </span>&nbsp;<span class=citation><a name=d12294e1412 class=n-a></a>Chen JJ, Huang W, Gui JP, <i> et al.</i>: A novel linkage to generalized vitiligo on 4q13-q21 identified in a genomewide linkage analysis of Chinese families. <i>Am J Hum Genet.</i> 2005; <b>76</b>(6): 10571065. <a target=xrefwindow id=d12294e1423 href="http://www.ncbi.nlm.nih.gov/pubmed/15809929">PubMed Abstract </a> | <a target=xrefwindow id=d12294e1426 href="http://dx.doi.org/10.1086/430279">Publisher Full Text </a> | <a target=xrefwindow id=d12294e1430 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1196443">Free Full Text </a></span></li><li><a name=ref-29 class=n-a></a><span class=label>29. </span>&nbsp;<span class=citation><a name=d12294e1439 class=n-a></a>Ren Y, Yang S, Xu S, <i> et al.</i>: Genetic variation of promoter sequence modulates XBP1 expression and genetic risk for vitiligo. <i>PLoS Genet.</i> 2009; <b>5</b>(6): e1000523. <a target=xrefwindow id=d12294e1450 href="http://www.ncbi.nlm.nih.gov/pubmed/19543371">PubMed Abstract </a> | <a target=xrefwindow id=d12294e1453 href="http://dx.doi.org/10.1371/journal.pgen.1000523">Publisher Full Text </a> | <a target=xrefwindow id=d12294e1457 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2689933">Free Full Text </a></span></li><li><a name=ref-30 class=n-a></a><span class=label>30. </span>&nbsp;<span class=citation><a name=d12294e1467 class=n-a></a>Birlea SA, Jin Y, Bennett DC, <i> et al.</i>: Comprehensive association analysis of candidate genes for generalized vitiligo supports <i>XBP1, FOXP3,</i> and <i>TSLP</i>. <i>J Invest Dermatol.</i> 2011; <b>131</b>(2): 37181. <a target=xrefwindow id=d12294e1485 href="http://www.ncbi.nlm.nih.gov/pubmed/21085187">PubMed Abstract </a> | <a target=xrefwindow id=d12294e1488 href="http://dx.doi.org/10.1038/jid.2010.337">Publisher Full Text </a> | <a target=xrefwindow id=d12294e1491 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3172683">Free Full Text </a></span></li><li><a name=ref-31 class=n-a></a><span class=label>31. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/1087723"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12294e1500 class=n-a></a>Acosta-Alvear D, Zhou Y, Blais A, <i> et al.</i>: XBP1 controls diverse cell type- and condition-specific transcriptional regulatory networks. <i>Mol Cell.</i> 2007; <b>27</b>(1): 5366. <a target=xrefwindow id=d12294e1511 href="http://www.ncbi.nlm.nih.gov/pubmed/17612490">PubMed Abstract </a> | <a target=xrefwindow id=d12294e1514 href="http://dx.doi.org/10.1016/j.molcel.2007.06.011">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/1087723">F1000 Recommendation</a></span></li><li><a name=ref-32 class=n-a></a><span class=label>32. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/717971062"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12294e1527 class=n-a></a>Harris JE, Harris TH, Weninger W, <i> et al.</i>: A mouse model of vitiligo with focused epidermal depigmentation requires IFN- for autoreactive CD8<sup>+</sup> T-cell accumulation in the skin. <i>J Invest Dermatol.</i> 2012; <b>132</b>(7): 186976. <a target=xrefwindow id=d12294e1541 href="http://www.ncbi.nlm.nih.gov/pubmed/22297636">PubMed Abstract </a> | <a target=xrefwindow id=d12294e1545 href="http://dx.doi.org/10.1038/jid.2011.463">Publisher Full Text </a> | <a target=xrefwindow id=d12294e1548 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3343174">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/717971062">F1000 Recommendation</a></span></li><li><a name=ref-33 class=n-a></a><span class=label>33. </span>&nbsp;<span class=citation><a name=d12294e1561 class=n-a></a>Shi F, Erf GF: IFN-, IL-21, and IL-10 co-expression in evolving autoimmune vitiligo lesions of Smyth line chickens. <i>J Invest Dermatol.</i> 2012; <b>132</b>(3 Pt 1): 6429. <a target=xrefwindow id=d12294e1569 href="http://www.ncbi.nlm.nih.gov/pubmed/22113479">PubMed Abstract </a> | <a target=xrefwindow id=d12294e1572 href="http://dx.doi.org/10.1038/jid.2011.377">Publisher Full Text </a> | <a target=xrefwindow id=d12294e1575 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3278581">Free Full Text </a></span></li><li><a name=ref-34 class=n-a></a><span class=label>34. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/725369905"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12294e1584 class=n-a></a>Yang L, Wei Y, Sun Y, <i> et al.</i>: Interferon-gamma Inhibits Melanogenesis and Induces Apoptosis in Melanocytes: A Pivotal Role of CD8+ Cytotoxic T Lymphocytes in Vitiligo. <i>Acta Derm Venereol.</i> 2015; <b>95</b>(6): 66470. <a target=xrefwindow id=d12294e1595 href="http://www.ncbi.nlm.nih.gov/pubmed/25721262">PubMed Abstract </a> | <a target=xrefwindow id=d12294e1598 href="http://dx.doi.org/10.2340/00015555-2080">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/725369905">F1000 Recommendation</a></span></li><li><a name=ref-35 class=n-a></a><span class=label>35. </span>&nbsp;<span class=citation><a name=d12294e1611 class=n-a></a>Harris JE: IFN- in Vitiligo, Is It the Fuel or the Fire? <i>Acta Derm Venereol.</i> 2015; <b>95</b>(6): 6434. <a target=xrefwindow id=d12294e1619 href="http://www.ncbi.nlm.nih.gov/pubmed/26059003">PubMed Abstract </a> | <a target=xrefwindow id=d12294e1622 href="http://dx.doi.org/10.2340/00015555-2137">Publisher Full Text </a></span></li><li><a name=ref-36 class=n-a></a><span class=label>36. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/726695901"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12294e1632 class=n-a></a>Singh RK, Lee KM, Vujkovic-Cvijin I, <i> et al.</i>: The role of IL-17 in vitiligo: A review. <i>Autoimmun Rev.</i> 2016; <b>15</b>(4): 397404. <a target=xrefwindow id=d12294e1643 href="http://www.ncbi.nlm.nih.gov/pubmed/26804758">PubMed Abstract </a> | <a target=xrefwindow id=d12294e1646 href="http://dx.doi.org/10.1016/j.autrev.2016.01.004">Publisher Full Text </a> | <a target=xrefwindow id=d12294e1650 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4769658">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/726695901">F1000 Recommendation</a></span></li><li><a name=ref-37 class=n-a></a><span class=label>37. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/725321532"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12294e1663 class=n-a></a>Zhou L, Shi YL, Li K, <i> et al.</i>: Increased circulating Th17 cells and elevated serum levels of TGF-beta and IL-21 are correlated with human non-segmental vitiligo development. <i>Pigment Cell Melanoma Res.</i> 2015; <b>28</b>(3): 3249. <a target=xrefwindow id=d12294e1674 href="http://www.ncbi.nlm.nih.gov/pubmed/25604047">PubMed Abstract </a> | <a target=xrefwindow id=d12294e1677 href="http://dx.doi.org/10.1111/pcmr.12355">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/725321532">F1000 Recommendation</a></span></li><li><a name=ref-38 class=n-a></a><span class=label>38. </span>&nbsp;<span class=citation><a name=d12294e1690 class=n-a></a>Shi F, Kong BW, Song JJ, <i> et al.</i>: Understanding mechanisms of vitiligo development in Smyth line of chickens by transcriptomic microarray analysis of evolving autoimmune lesions. <i>BMC Immunol.</i> 2012; <b>13</b>: 18. <a target=xrefwindow id=d12294e1701 href="http://www.ncbi.nlm.nih.gov/pubmed/22500953">PubMed Abstract </a> | <a target=xrefwindow id=d12294e1704 href="http://dx.doi.org/10.1186/1471-2172-13-18">Publisher Full Text </a> | <a target=xrefwindow id=d12294e1708 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3353230">Free Full Text </a></span></li><li><a name=ref-39 class=n-a></a><span class=label>39. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/725620299"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12294e1717 class=n-a></a>Webb KC, Tung R, Winterfield LS, <i> et al.</i>: Tumour necrosis factor- inhibition can stabilize disease in progressive vitiligo. <i>Br J Dermatol.</i> 2015; <b>173</b>(3): 64150. <a target=xrefwindow id=d12294e1728 href="http://www.ncbi.nlm.nih.gov/pubmed/26149498">PubMed Abstract </a> | <a target=xrefwindow id=d12294e1731 href="http://dx.doi.org/10.1111/bjd.14016">Publisher Full Text </a> | <a target=xrefwindow id=d12294e1735 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4583813">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/725620299">F1000 Recommendation</a></span></li><li><a name=ref-40 class=n-a></a><span class=label>40. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/1123862"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12294e1748 class=n-a></a>Spolski R, Kashyap M, Robinson C, <i> et al.</i>: IL-21 signaling is critical for the development of type I diabetes in the NOD mouse. <i>Proc Natl Acad Sci U S A.</i> 2008; <b>105</b>(37): 1402833. <a target=xrefwindow id=d12294e1759 href="http://www.ncbi.nlm.nih.gov/pubmed/18779574">PubMed Abstract </a> | <a target=xrefwindow id=d12294e1762 href="http://dx.doi.org/10.1073/pnas.0804358105">Publisher Full Text </a> | <a target=xrefwindow id=d12294e1766 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2544573">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/1123862">F1000 Recommendation</a></span></li><li><a name=ref-41 class=n-a></a><span class=label>41. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/1091351"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12294e1779 class=n-a></a>Allard EL, Hardy MP, Leignadier J, <i> et al.</i>: Overexpression of IL-21 promotes massive CD8<sup>+</sup> memory T cell accumulation. <i>Eur J Immunol.</i> 2007; <b>37</b>(11): 306977. <a target=xrefwindow id=d12294e1793 href="http://www.ncbi.nlm.nih.gov/pubmed/17918202">PubMed Abstract </a> | <a target=xrefwindow id=d12294e1797 href="http://dx.doi.org/10.1002/eji.200637017">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/1091351">F1000 Recommendation</a></span></li><li><a name=ref-42 class=n-a></a><span class=label>42. </span>&nbsp;<span class=citation><a name=d12294e1811 class=n-a></a>Liu S, Lize G, Lou Y, <i> et al.</i>: IL-21 synergizes with IL-7 to augment expansion and anti-tumor function of cytotoxic T cells. <i>Int Immunol.</i> 2007; <b>19</b>(10): 121321. <a target=xrefwindow id=d12294e1822 href="http://www.ncbi.nlm.nih.gov/pubmed/17898044">PubMed Abstract </a> | <a target=xrefwindow id=d12294e1825 href="http://dx.doi.org/10.1093/intimm/dxm093">Publisher Full Text </a></span></li><li><a name=ref-43 class=n-a></a><span class=label>43. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/726086459"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12294e1834 class=n-a></a>Cavalli G, Hayashi M, Jin Y, <i> et al.</i>: MHC class II super-enhancer increases surface expression of HLA-DR and HLA-DQ and affects cytokine production in autoimmune vitiligo. <i>Proc Natl Acad Sci U S A.</i> 2016; <b>113</b>(5): 13638. <a target=xrefwindow id=d12294e1845 href="http://www.ncbi.nlm.nih.gov/pubmed/26787888">PubMed Abstract </a> | <a target=xrefwindow id=d12294e1848 href="http://dx.doi.org/10.1073/pnas.1523482113">Publisher Full Text </a> | <a target=xrefwindow id=d12294e1852 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4747741">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/726086459">F1000 Recommendation</a></span></li><li><a name=ref-44 class=n-a></a><span class=label>44. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/726086458"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12294e1865 class=n-a></a>Hayashi M, Jin Y, Yorgov D, <i> et al.</i>: Autoimmune vitiligo is associated with gain-of-function by a transcriptional regulator that elevates expression of <i>HLA-A*02:01 in vivo</i>. <i>Proc Natl Acad Sci U S A.</i> 2016; <b>113</b>(5): 135762. <a target=xrefwindow id=d12294e1879 href="http://www.ncbi.nlm.nih.gov/pubmed/26787886">PubMed Abstract </a> | <a target=xrefwindow id=d12294e1883 href="http://dx.doi.org/10.1073/pnas.1525001113">Publisher Full Text </a> | <a target=xrefwindow id=d12294e1886 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4747738">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/726086458">F1000 Recommendation</a></span></li><li><a name=ref-45 class=n-a></a><span class=label>45. </span>&nbsp;<span class=citation><a name=d12294e1899 class=n-a></a>Jin Y, Ferrara T, Gowan K, <i> et al.</i>: Next-generation DNA re-sequencing identifies common variants of <i>TYR</i> and <i>HLA-A</i> that modulate the risk of generalized vitiligo via antigen presentation. <i>J Invest Dermatol.</i> 2012; <b>132</b>(6): 17303. <a target=xrefwindow id=d12294e1917 href="http://www.ncbi.nlm.nih.gov/pubmed/22402439">PubMed Abstract </a> | <a target=xrefwindow id=d12294e1920 href="http://dx.doi.org/10.1038/jid.2012.37">Publisher Full Text </a> | <a target=xrefwindow id=d12294e1923 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3513338">Free Full Text </a></span></li><li><a name=ref-46 class=n-a></a><span class=label>46. </span>&nbsp;<span class=citation><a name=d12294e1932 class=n-a></a>El Mofty M, Bosseila M, Mashaly HM, <i> et al.</i>: Broadband ultraviolet A vs. psoralen ultraviolet A in the treatment of vitiligo: a randomized controlled trial. <i>Clin Exp Dermatol.</i> 2013; <b>38</b>(8): 8305. <a target=xrefwindow id=d12294e1943 href="http://www.ncbi.nlm.nih.gov/pubmed/23551324">PubMed Abstract </a> | <a target=xrefwindow id=d12294e1946 href="http://dx.doi.org/10.1111/ced.12099">Publisher Full Text </a></span></li><li><a name=ref-47 class=n-a></a><span class=label>47. </span>&nbsp;<span class=citation><a name=d12294e1955 class=n-a></a>Garg BJ, Saraswat A, Bhatia A, <i> et al.</i>: Topical treatment in vitiligo and the potential uses of new drug delivery systems. <i>Indian J Dermatol Venereol Leprol.</i> 2010; <b>76</b>(3): 2318. <a target=xrefwindow id=d12294e1966 href="http://www.ncbi.nlm.nih.gov/pubmed/20445292">PubMed Abstract </a> | <a target=xrefwindow id=d12294e1969 href="http://dx.doi.org/10.4103/0378-6323.62961">Publisher Full Text </a></span></li><li><a name=ref-48 class=n-a></a><span class=label>48. </span>&nbsp;<span class=citation><a name=d12294e1979 class=n-a></a>Ho N, Pope E, Weinstein M, <i> et al.</i>: A double-blind, randomized, placebo-controlled trial of topical tacrolimus 01% vs. clobetasol propionate 005% in childhood vitiligo. <i>Br J Dermatol.</i> 2011; <b>165</b>(3): 62632. <a target=xrefwindow id=d12294e1990 href="http://www.ncbi.nlm.nih.gov/pubmed/21457214">PubMed Abstract </a> | <a target=xrefwindow id=d12294e1993 href="http://dx.doi.org/10.1111/j.1365-2133.2011.10351.x">Publisher Full Text </a></span></li><li><a name=ref-49 class=n-a></a><span class=label>49. </span>&nbsp;<span class=citation><a name=d12294e2002 class=n-a></a>Kse O, Arca E, Kurumlu Z: Mometasone cream versus pimecrolimus cream for the treatment of childhood localized vitiligo. <i>J Dermatolog Treat.</i> 2010; <b>21</b>(3): 1339. <a target=xrefwindow id=d12294e2010 href="http://www.ncbi.nlm.nih.gov/pubmed/20394489">PubMed Abstract </a> | <a target=xrefwindow id=d12294e2013 href="http://dx.doi.org/10.3109/09546630903266761">Publisher Full Text </a></span></li><li><a name=ref-50 class=n-a></a><span class=label>50. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/8628956"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12294e2022 class=n-a></a>Le Duff F, Fontas E, Giacchero D, <i> et al.</i>: 308-nm excimer lamp vs. 308-nm excimer laser for treating vitiligo: a randomized study. <i>Br J Dermatol.</i> 2010; <b>163</b>(1): 18892. <a target=xrefwindow id=d12294e2033 href="http://www.ncbi.nlm.nih.gov/pubmed/20346025">PubMed Abstract </a> | <a target=xrefwindow id=d12294e2036 href="http://dx.doi.org/10.1111/j.1365-2133.2010.09778.x">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/8628956">F1000 Recommendation</a></span></li><li><a name=ref-51 class=n-a></a><span class=label>51. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/717978517"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12294e2049 class=n-a></a>Shi Q, Li K, Fu J, <i> et al.</i>: Comparison of the 308-nm excimer laser with the 308-nm excimer lamp in the treatment of vitiligo--a randomized bilateral comparison study. <i>Photodermatol Photoimmunol Photomed.</i> 2013; <b>29</b>(1): 2733. <a target=xrefwindow id=d12294e2060 href="http://www.ncbi.nlm.nih.gov/pubmed/23281694">PubMed Abstract </a> | <a target=xrefwindow id=d12294e2063 href="http://dx.doi.org/10.1111/phpp.12015">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/717978517">F1000 Recommendation</a></span></li><li><a name=ref-52 class=n-a></a><span class=label>52. </span>&nbsp;<span class=citation><a name=d12294e2076 class=n-a></a>Verhaeghe E, Lodewick E, van Geel N, <i> et al.</i>: Intrapatient comparison of 308-nm monochromatic excimer light and localized narrow-band UVB phototherapy in the treatment of vitiligo: a randomized controlled trial. <i>Dermatology.</i> 2011; <b>223</b>(4): 3438. <a target=xrefwindow id=d12294e2087 href="http://www.ncbi.nlm.nih.gov/pubmed/22269666">PubMed Abstract </a> | <a target=xrefwindow id=d12294e2090 href="http://dx.doi.org/10.1159/000335272">Publisher Full Text </a></span></li><li><a name=ref-53 class=n-a></a><span class=label>53. </span>&nbsp;<span class=citation><a name=d12294e2099 class=n-a></a>Anbar TS, El-Sawy AE, Attia SK, <i> et al.</i>: Effect of PUVA therapy on melanocytes and keratinocytes in non-segmental vitiligo: histopathological, immuno-histochemical and ultrastructural study. <i>Photodermatol Photoimmunol Photomed.</i> 2012; <b>28</b>(1): 1725. <a target=xrefwindow id=d12294e2110 href="http://www.ncbi.nlm.nih.gov/pubmed/22211999">PubMed Abstract </a> | <a target=xrefwindow id=d12294e2113 href="http://dx.doi.org/10.1111/j.1600-0781.2011.00631.x">Publisher Full Text </a></span></li><li><a name=ref-54 class=n-a></a><span class=label>54. </span>&nbsp;<span class=citation><a name=d12294e2123 class=n-a></a>Bansal S, Sahoo B, Garg V: Psoralen-narrowband UVB phototherapy for the treatment of vitiligo in comparison to narrowband UVB alone. <i>Photodermatol Photoimmunol Photomed.</i> 2013; <b>29</b>(6): 3117. <a target=xrefwindow id=d12294e2131 href="http://www.ncbi.nlm.nih.gov/pubmed/24118425">PubMed Abstract </a> | <a target=xrefwindow id=d12294e2134 href="http://dx.doi.org/10.1111/phpp.12072">Publisher Full Text </a></span></li><li><a name=ref-55 class=n-a></a><span class=label>55. </span>&nbsp;<span class=citation><a name=d12294e2143 class=n-a></a>El-Zawahry BM, Bassiouny DA, Sobhi RM, <i> et al.</i>: A comparative study on efficacy of UVA1 vs. narrow-band UVB phototherapy in the treatment of vitiligo. <i>Photodermatol Photoimmunol Photomed.</i> 2012; <b>28</b>(2): 8490. <a target=xrefwindow id=d12294e2154 href="http://www.ncbi.nlm.nih.gov/pubmed/22409711">PubMed Abstract </a> | <a target=xrefwindow id=d12294e2157 href="http://dx.doi.org/10.1111/j.1600-0781.2011.00643.x">Publisher Full Text </a></span></li><li><a name=ref-56 class=n-a></a><span class=label>56. </span>&nbsp;<span class=citation><a name=d12294e2166 class=n-a></a>Singh S, Khandpur S, Sharma VK, <i> et al.</i>: Comparison of efficacy and side-effect profile of oral PUVA vs. oral PUVA sol in the treatment of vitiligo: a 36-week prospective study. <i>J Eur Acad Dermatol Venereol.</i> 2013; <b>27</b>(11): 134451. <a target=xrefwindow id=d12294e2177 href="http://www.ncbi.nlm.nih.gov/pubmed/23066663">PubMed Abstract </a> | <a target=xrefwindow id=d12294e2180 href="http://dx.doi.org/10.1111/jdv.12002">Publisher Full Text </a></span></li><li><a name=ref-57 class=n-a></a><span class=label>57. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/726695904"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12294e2189 class=n-a></a>Akdeniz N, Yavuz IH, Gunes Bilgili S, <i> et al.</i>: Comparison of efficacy of narrow band UVB therapies with UVB alone, in combination with calcipotriol, and with betamethasone and calcipotriol in vitiligo. <i>J Dermatolog Treat.</i> 2014; <b>25</b>(3): 1969. <a target=xrefwindow id=d12294e2200 href="http://www.ncbi.nlm.nih.gov/pubmed/23441902">PubMed Abstract </a> | <a target=xrefwindow id=d12294e2203 href="http://dx.doi.org/10.3109/09546634.2013.777381">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/726695904">F1000 Recommendation</a></span></li><li><a name=ref-58 class=n-a></a><span class=label>58. </span>&nbsp;<span class=citation><a name=d12294e2216 class=n-a></a>Baldo A, Lodi G, Di Caterino P, <i> et al.</i>: Vitiligo, NB-UVB and tacrolimus: our experience in Naples. <i>G Ital Dermatol Venereol.</i> 2014; <b>149</b>(1): 12330. <a target=xrefwindow id=d12294e2227 href="http://www.ncbi.nlm.nih.gov/pubmed/24566573">PubMed Abstract </a></span></li><li><a name=ref-59 class=n-a></a><span class=label>59. </span>&nbsp;<span class=citation><a name=d12294e2236 class=n-a></a>Majid I: Does topical tacrolimus ointment enhance the efficacy of narrowband ultraviolet B therapy in vitiligo? A left-right comparison study. <i>Photodermatol Photoimmunol Photomed.</i> 2010; <b>26</b>(5): 2304. <a target=xrefwindow id=d12294e2244 href="http://www.ncbi.nlm.nih.gov/pubmed/20831696">PubMed Abstract </a> | <a target=xrefwindow id=d12294e2247 href="http://dx.doi.org/10.1111/j.1600-0781.2010.00540.x">Publisher Full Text </a></span></li><li><a name=ref-60 class=n-a></a><span class=label>60. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/13437046"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12294e2257 class=n-a></a>Nordal EJ, Guleng GE, Rnnevig JR: Treatment of vitiligo with narrowband-UVB (TL01) combined with tacrolimus ointment (0.1%) vs. placebo ointment, a randomized right/left double-blind comparative study. <i>J Eur Acad Dermatol Venereol.</i> 2011; <b>25</b>(12): 14403. <a target=xrefwindow id=d12294e2265 href="http://www.ncbi.nlm.nih.gov/pubmed/21466589">PubMed Abstract </a> | <a target=xrefwindow id=d12294e2268 href="http://dx.doi.org/10.1111/j.1468-3083.2011.04002.x">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/13437046">F1000 Recommendation</a></span></li><li><a name=ref-61 class=n-a></a><span class=label>61. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/725290482"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12294e2281 class=n-a></a>Anbar TS, El-Ammawi TS, Abdel-Rahman AT, <i> et al.</i>: The effect of latanoprost on vitiligo: a preliminary comparative study. <i>Int J Dermatol.</i> 2015; <b>54</b>(5): 58793. <a target=xrefwindow id=d12294e2292 href="http://www.ncbi.nlm.nih.gov/pubmed/25545321">PubMed Abstract </a> | <a target=xrefwindow id=d12294e2295 href="http://dx.doi.org/10.1111/ijd.12631">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/725290482">F1000 Recommendation</a></span></li><li><a name=ref-62 class=n-a></a><span class=label>62. </span>&nbsp;<span class=citation><a name=d12294e2308 class=n-a></a>Kapoor R, Phiske MM, Jerajani HR: Evaluation of safety and efficacy of topical prostaglandin E<sub>2</sub> in treatment of vitiligo. <i>Br J Dermatol.</i> 2009; <b>160</b>(4): 8613. <a target=xrefwindow id=d12294e2319 href="http://www.ncbi.nlm.nih.gov/pubmed/19014395">PubMed Abstract </a> | <a target=xrefwindow id=d12294e2322 href="http://dx.doi.org/10.1111/j.1365-2133.2008.08923.x">Publisher Full Text </a></span></li><li><a name=ref-63 class=n-a></a><span class=label>63. </span>&nbsp;<span class=citation><a name=d12294e2331 class=n-a></a>Parsad D, Pandhi R, Dogra S, <i> et al.</i>: Topical prostaglandin analog (PGE<sub>2</sub>) in vitiligo--a preliminary study. <i>Int J Dermatol.</i> 2002; <b>41</b>(12): 9425. <a target=xrefwindow id=d12294e2345 href="http://www.ncbi.nlm.nih.gov/pubmed/12492997">PubMed Abstract </a> | <a target=xrefwindow id=d12294e2349 href="http://dx.doi.org/10.1046/j.1365-4362.2002.01612.x">Publisher Full Text </a></span></li><li><a name=ref-64 class=n-a></a><span class=label>64. </span>&nbsp;<span class=citation><a name=d12294e2358 class=n-a></a>Anbar TS, Hegazy RA, Picardo M, <i> et al.</i>: Beyond vitiligo guidelines: combined stratified/personalized approaches for the vitiligo patient. <i>Exp Dermatol.</i> 2014; <b>23</b>(4): 21923. <a target=xrefwindow id=d12294e2369 href="http://www.ncbi.nlm.nih.gov/pubmed/24521008">PubMed Abstract </a> | <a target=xrefwindow id=d12294e2372 href="http://dx.doi.org/10.1111/exd.12344">Publisher Full Text </a></span></li><li><a name=ref-65 class=n-a></a><span class=label>65. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/718039864"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12294e2381 class=n-a></a>Kanwar AJ, Mahajan R, Parsad D: Low-dose oral mini-pulse dexamethasone therapy in progressive unstable vitiligo. <i>J Cutan Med Surg.</i> 2013; <b>17</b>(4): 25968. <a target=xrefwindow id=d12294e2389 href="http://www.ncbi.nlm.nih.gov/pubmed/23815959">PubMed Abstract </a> | <a target=xrefwindow id=d12294e2392 href="http://dx.doi.org/10.2310/7750.2013.12053">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/718039864">F1000 Recommendation</a></span></li><li><a name=ref-66 class=n-a></a><span class=label>66. </span>&nbsp;<span class=citation><a name=d12294e2406 class=n-a></a>Lee DY, Kim CR, Lee JH, <i> et al.</i>: Recent onset vitiligo treated with systemic corticosteroid and topical tacrolimus: Need for early treatment in vitiligo. <i>J Dermatol.</i> 2010; <b>37</b>(12): 10579. <a target=xrefwindow id=d12294e2417 href="http://www.ncbi.nlm.nih.gov/pubmed/21083711">PubMed Abstract </a> | <a target=xrefwindow id=d12294e2420 href="http://dx.doi.org/10.1111/j.1346-8138.2010.00929.x">Publisher Full Text </a></span></li><li><a name=ref-67 class=n-a></a><span class=label>67. </span>&nbsp;<span class=citation><a name=d12294e2429 class=n-a></a>Parsad D, Kanwar A: Oral minocycline in the treatment of vitiligo--a preliminary study. <i>Dermatol Ther.</i> 2010; <b>23</b>(3): 3057. <a target=xrefwindow id=d12294e2437 href="http://www.ncbi.nlm.nih.gov/pubmed/20597950">PubMed Abstract </a> | <a target=xrefwindow id=d12294e2440 href="http://dx.doi.org/10.1111/j.1529-8019.2010.01328.x">Publisher Full Text </a></span></li><li><a name=ref-68 class=n-a></a><span class=label>68. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/722888986"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12294e2449 class=n-a></a>Singh A, Kanwar AJ, Parsad D, <i> et al.</i>: Randomized controlled study to evaluate the effectiveness of dexamethasone oral minipulse therapy versus oral minocycline in patients with active vitiligo vulgaris. <i>Indian J Dermatol Venereol Leprol.</i> 2014; <b>80</b>(1): 2935. <a target=xrefwindow id=d12294e2460 href="http://www.ncbi.nlm.nih.gov/pubmed/24448120">PubMed Abstract </a> | <a target=xrefwindow id=d12294e2463 href="http://dx.doi.org/10.4103/0378-6323.125479">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/722888986">F1000 Recommendation</a></span></li><li><a name=ref-69 class=n-a></a><span class=label>69. </span>&nbsp;<span class=citation><a name=d12294e2476 class=n-a></a>Song X, Xu A, Pan W, <i> et al.</i>: Minocycline protects melanocytes against H2O2-induced cell death via JNK and p38 MAPK pathways. <i>Int J Mol Med.</i> 2008; <b>22</b>(1): 916. <a target=xrefwindow id=d12294e2487 href="http://www.ncbi.nlm.nih.gov/pubmed/18575770">PubMed Abstract </a> | <a target=xrefwindow id=d12294e2490 href="http://dx.doi.org/10.3892/ijmm.22.1.9">Publisher Full Text </a></span></li><li><a name=ref-70 class=n-a></a><span class=label>70. </span>&nbsp;<span class=citation><a name=d12294e2499 class=n-a></a>Feily A, Baktash D, Mohebbipour A: Potential advantages of simvastatin as a novel anti-vitiligo arsenal. <i>Eur Rev Med Pharmacol Sci.</i> 2013; <b>17</b>(14): 19823. <a target=xrefwindow id=d12294e2507 href="http://www.ncbi.nlm.nih.gov/pubmed/23877867">PubMed Abstract </a></span></li><li><a name=ref-71 class=n-a></a><span class=label>71. </span>&nbsp;<span class=citation><a name=d12294e2516 class=n-a></a>Namazi MR: Statins: novel additions to the dermatologic arsenal? <i>Exp Dermatol.</i> 2004; <b>13</b>(6): 3379. <a target=xrefwindow id=d12294e2524 href="http://www.ncbi.nlm.nih.gov/pubmed/15186318">PubMed Abstract </a> | <a target=xrefwindow id=d12294e2527 href="http://dx.doi.org/10.1111/j.0906-6705.2004.00208.x">Publisher Full Text </a></span></li><li><a name=ref-72 class=n-a></a><span class=label>72. </span>&nbsp;<span class=citation><a name=d12294e2537 class=n-a></a>Nol M, Gagn C, Bergeron J, <i> et al.</i>: Positive pleiotropic effects of HMG-CoA reductase inhibitor on vitiligo. <i>Lipids Health Dis.</i> 2004; <b>3</b>: 7. <a target=xrefwindow id=d12294e2548 href="http://www.ncbi.nlm.nih.gov/pubmed/15134579">PubMed Abstract </a> | <a target=xrefwindow id=d12294e2551 href="http://dx.doi.org/10.1186/1476-511X-3-7">Publisher Full Text </a> | <a target=xrefwindow id=d12294e2555 href="http://www.ncbi.nlm.nih.gov/pmc/articles/425594">Free Full Text </a></span></li><li><a name=ref-73 class=n-a></a><span class=label>73. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/725282599"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12294e2564 class=n-a></a>Agarwal P, Rashighi M, Essien KI, <i> et al.</i>: Simvastatin prevents and reverses depigmentation in a mouse model of vitiligo. <i>J Invest Dermatol.</i> 2015; <b>135</b>(4): 10808. <a target=xrefwindow id=d12294e2575 href="http://www.ncbi.nlm.nih.gov/pubmed/25521459">PubMed Abstract </a> | <a target=xrefwindow id=d12294e2578 href="http://dx.doi.org/10.1038/jid.2014.529">Publisher Full Text </a> | <a target=xrefwindow id=d12294e2582 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4366328">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/725282599">F1000 Recommendation</a></span></li><li><a name=ref-74 class=n-a></a><span class=label>74. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/725585478"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12294e2595 class=n-a></a>Craiglow BG, King BA: Tofacitinib Citrate for the Treatment of Vitiligo: A Pathogenesis-Directed Therapy. <i>JAMA Dermatol.</i> 2015; <b>151</b>(10): 11102. <a target=xrefwindow id=d12294e2603 href="http://www.ncbi.nlm.nih.gov/pubmed/26107994">PubMed Abstract </a> | <a target=xrefwindow id=d12294e2606 href="http://dx.doi.org/10.1001/jamadermatol.2015.1520">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/725585478">F1000 Recommendation</a></span></li><li><a name=ref-75 class=n-a></a><span class=label>75. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/726695907"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12294e2619 class=n-a></a>Harris JE, Rashighi M, Nguyen N, <i> et al.</i>: Rapid skin repigmentation on oral ruxolitinib in a patient with coexistent vitiligo and alopecia areata (AA). <i>J Am Acad Dermatol.</i> 2016; <b>74</b>(2): 3701. <a target=xrefwindow id=d12294e2630 href="http://www.ncbi.nlm.nih.gov/pubmed/26685721">PubMed Abstract </a> | <a target=xrefwindow id=d12294e2633 href="http://dx.doi.org/10.1016/j.jaad.2015.09.073">Publisher Full Text </a> | <a target=xrefwindow id=d12294e2637 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4718770">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/726695907">F1000 Recommendation</a></span></li><li><a name=ref-76 class=n-a></a><span class=label>76. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/718276019"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12294e2650 class=n-a></a>Rashighi M, Agarwal P, Richmond JM, <i> et al.</i>: CXCL10 is critical for the progression and maintenance of depigmentation in a mouse model of vitiligo. <i>Sci Transl Med.</i> 2014; <b>6</b>(223): 223ra23. <a target=xrefwindow id=d12294e2661 href="http://www.ncbi.nlm.nih.gov/pubmed/24523323">PubMed Abstract </a> | <a target=xrefwindow id=d12294e2664 href="http://dx.doi.org/10.1126/scitranslmed.3007811">Publisher Full Text </a> | <a target=xrefwindow id=d12294e2668 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4086941">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/718276019">F1000 Recommendation</a></span></li><li><a name=ref-77 class=n-a></a><span class=label>77. </span>&nbsp;<span class=citation><a name=d12294e2681 class=n-a></a>Antoniou C, Schulpis H, Michas T, <i> et al.</i>: Vitiligo therapy with oral and topical phenylalanine with UVA exposure. <i>Int J Dermatol.</i> 1989; <b>28</b>(8): 5457. <a target=xrefwindow id=d12294e2692 href="http://www.ncbi.nlm.nih.gov/pubmed/2583897">PubMed Abstract </a> | <a target=xrefwindow id=d12294e2695 href="http://dx.doi.org/10.1111/j.1365-4362.1989.tb04613.x">Publisher Full Text </a></span></li><li><a name=ref-78 class=n-a></a><span class=label>78. </span>&nbsp;<span class=citation><a name=d12294e2705 class=n-a></a>Dell'Anna ML, Mastrofrancesco A, Sala R, <i> et al.</i>: Antioxidants and narrow band-UVB in the treatment of vitiligo: a double-blind placebo controlled trial. <i>Clin Exp Dermatol.</i> 2007; <b>32</b>(6): 6316. <a target=xrefwindow id=d12294e2716 href="http://www.ncbi.nlm.nih.gov/pubmed/17953631">PubMed Abstract </a> | <a target=xrefwindow id=d12294e2719 href="http://dx.doi.org/10.1111/j.1365-2230.2007.02514.x">Publisher Full Text </a></span></li><li><a name=ref-79 class=n-a></a><span class=label>79. </span>&nbsp;<span class=citation><a name=d12294e2728 class=n-a></a>Elgoweini M, Nour El Din N: Response of vitiligo to narrowband ultraviolet B and oral antioxidants. <i>J Clin Pharmacol.</i> 2009; <b>49</b>(7): 8525. <a target=xrefwindow id=d12294e2736 href="http://www.ncbi.nlm.nih.gov/pubmed/19553407">PubMed Abstract </a> | <a target=xrefwindow id=d12294e2739 href="http://dx.doi.org/10.1177/0091270009335769">Publisher Full Text </a></span></li><li><a name=ref-80 class=n-a></a><span class=label>80. </span>&nbsp;<span class=citation><a name=d12294e2748 class=n-a></a>Juhlin L, Olsson MJ: Improvement of vitiligo after oral treatment with vitamin B12 and folic acid and the importance of sun exposure. <i>Acta Derm Venereol.</i> 1997; <b>77</b>(6): 4602. <a target=xrefwindow id=d12294e2756 href="http://www.ncbi.nlm.nih.gov/pubmed/9394983">PubMed Abstract </a></span></li><li><a name=ref-81 class=n-a></a><span class=label>81. </span>&nbsp;<span class=citation><a name=d12294e2765 class=n-a></a>Mohammad A: Vitiligo repigmentation with Anapsos (<i>Polypodium leucotomos</i>). <i>Int J Dermatol.</i> 1989; <b>28</b>(7): 479. <a target=xrefwindow id=d12294e2776 href="http://www.ncbi.nlm.nih.gov/pubmed/2777452">PubMed Abstract </a> | <a target=xrefwindow id=d12294e2779 href="http://dx.doi.org/10.1111/j.1365-4362.1989.tb02517.x">Publisher Full Text </a></span></li><li><a name=ref-82 class=n-a></a><span class=label>82. </span>&nbsp;<span class=citation><a name=d12294e2788 class=n-a></a>Morliere P, Hnigsmann H, Averbeck D, <i> et al.</i>: Phototherapeutic, photobiologic, and photosensitizing properties of khellin. <i>J Invest Dermatol.</i> 1988; <b>90</b>(5): 7204. <a target=xrefwindow id=d12294e2799 href="http://www.ncbi.nlm.nih.gov/pubmed/3283251">PubMed Abstract </a></span></li><li><a name=ref-83 class=n-a></a><span class=label>83. </span>&nbsp;<span class=citation><a name=d12294e2808 class=n-a></a>Siddiqui AH, Stolk LM, Bhaggoe R, <i> et al.</i>: <i>L</i>-phenylalanine and UVA irradiation in the treatment of vitiligo. <i>Dermatology.</i> 1994; <b>188</b>(3): 2158. <a target=xrefwindow id=d12294e2822 href="http://www.ncbi.nlm.nih.gov/pubmed/8186511">PubMed Abstract </a> | <a target=xrefwindow id=d12294e2826 href="http://dx.doi.org/10.1159/000247142">Publisher Full Text </a></span></li><li><a name=ref-84 class=n-a></a><span class=label>84. </span>&nbsp;<span class=citation><a name=d12294e2836 class=n-a></a>Yaghoobi R, Omidian M, Bagherani N: Original article title: "Comparison of therapeutic efficacy of topical corticosteroid and oral zinc sulfate-topical corticosteroid combination in the treatment of vitiligo patients: a clinical trial". <i>BMC Dermatol.</i> 2011; <b>11</b>: 7. <a target=xrefwindow id=d12294e2844 href="http://www.ncbi.nlm.nih.gov/pubmed/21453467">PubMed Abstract </a> | <a target=xrefwindow id=d12294e2847 href="http://dx.doi.org/10.1186/1471-5945-11-7">Publisher Full Text </a> | <a target=xrefwindow id=d12294e2850 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3079655">Free Full Text </a></span></li><li><a name=ref-85 class=n-a></a><span class=label>85. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/718205853"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12294e2859 class=n-a></a>Grimes PE, Hamzavi I, Lebwohl M, <i> et al.</i>: The efficacy of afamelanotide and narrowband UV-B phototherapy for repigmentation of vitiligo. <i>JAMA Dermatol.</i> 2013; <b>149</b>(1): 6873. <a target=xrefwindow id=d12294e2870 href="http://www.ncbi.nlm.nih.gov/pubmed/23407924">PubMed Abstract </a> | <a target=xrefwindow id=d12294e2873 href="http://dx.doi.org/10.1001/2013.jamadermatol.386">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/718205853">F1000 Recommendation</a></span></li><li><a name=ref-86 class=n-a></a><span class=label>86. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/726695909"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12294e2886 class=n-a></a>Lim HW, Grimes PE, Agbai O, <i> et al.</i>: Afamelanotide and narrowband UV-B phototherapy for the treatment of vitiligo: a randomized multicenter trial. <i>JAMA Dermatol.</i> 2015; <b>151</b>(1): 4250. <a target=xrefwindow id=d12294e2897 href="http://www.ncbi.nlm.nih.gov/pubmed/25230094">PubMed Abstract </a> | <a target=xrefwindow id=d12294e2900 href="http://dx.doi.org/10.1001/jamadermatol.2014.1875">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/726695909">F1000 Recommendation</a></span></li><li><a name=ref-87 class=n-a></a><span class=label>87. </span>&nbsp;<span class=citation><a name=d12294e2913 class=n-a></a>Passeron T: Indications and limitations of afamelanotide for treating vitiligo. <i>JAMA Dermatol.</i> 2015; <b>151</b>(3): 34950. <a target=xrefwindow id=d12294e2921 href="http://www.ncbi.nlm.nih.gov/pubmed/25607635">PubMed Abstract </a> | <a target=xrefwindow id=d12294e2924 href="http://dx.doi.org/10.1001/jamadermatol.2014.4848">Publisher Full Text </a></span></li><li><a name=ref-88 class=n-a></a><span class=label>88. </span>&nbsp;<span class=citation><a name=d12294e2933 class=n-a></a>Bayoumi W, Fontas E, Sillard L, <i> et al.</i>: Effect of a preceding laser dermabrasion on the outcome of combined therapy with narrowband ultraviolet B and potent topical steroids for treating nonsegmental vitiligo in resistant localizations. <i>Br J Dermatol.</i> 2012; <b>166</b>(1): 20811. <a target=xrefwindow id=d12294e2944 href="http://www.ncbi.nlm.nih.gov/pubmed/21824124">PubMed Abstract </a> | <a target=xrefwindow id=d12294e2947 href="http://dx.doi.org/10.1111/j.1365-2133.2011.10564.x">Publisher Full Text </a></span></li><li><a name=ref-89 class=n-a></a><span class=label>89. </span>&nbsp;<span class=citation><a name=d12294e2956 class=n-a></a>Shin J, Lee JS, Hann SK, <i> et al.</i>: Combination treatment by 10 600 nm ablative fractional carbon dioxide laser and narrowband ultraviolet B in refractory nonsegmental vitiligo: a prospective, randomized half-body comparative study. <i>Br J Dermatol.</i> 2012; <b>166</b>(3): 65861. <a target=xrefwindow id=d12294e2967 href="http://www.ncbi.nlm.nih.gov/pubmed/22050270">PubMed Abstract </a> | <a target=xrefwindow id=d12294e2970 href="http://dx.doi.org/10.1111/j.1365-2133.2011.10723.x">Publisher Full Text </a></span></li><li><a name=ref-90 class=n-a></a><span class=label>90. </span>&nbsp;<span class=citation><a name=d12294e2980 class=n-a></a>Feetham HJ, Chan JL, Pandya AG: Characterization of clinical response in patients with vitiligo undergoing autologous epidermal punch grafting. <i>Dermatol Surg.</i> 2012; <b>38</b>(1): 149. <a target=xrefwindow id=d12294e2988 href="http://www.ncbi.nlm.nih.gov/pubmed/22093284">PubMed Abstract </a> | <a target=xrefwindow id=d12294e2991 href="http://dx.doi.org/10.1111/j.1524-4725.2011.02171.x">Publisher Full Text </a></span></li><li><a name=ref-91 class=n-a></a><span class=label>91. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/725445080"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12294e3000 class=n-a></a>Gou D, Currimbhoy S, Pandya AG: Suction blister grafting for vitiligo: efficacy and clinical predictive factors. <i>Dermatol Surg.</i> 2015; <b>41</b>(5): 6339. <a target=xrefwindow id=d12294e3008 href="http://www.ncbi.nlm.nih.gov/pubmed/25899886">PubMed Abstract </a> | <a target=xrefwindow id=d12294e3011 href="http://dx.doi.org/10.1097/DSS.0000000000000341">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/725445080">F1000 Recommendation</a></span></li><li><a name=ref-92 class=n-a></a><span class=label>92. </span>&nbsp;<span class=citation><a name=d12294e3024 class=n-a></a>Mulekar SV, Isedeh P: Surgical interventions for vitiligo: an evidence-based review. <i>Br J Dermatol.</i> 2013; <b>169</b>(Suppl 3): 5766. <a target=xrefwindow id=d12294e3032 href="http://www.ncbi.nlm.nih.gov/pubmed/24098901">PubMed Abstract </a> | <a target=xrefwindow id=d12294e3035 href="http://dx.doi.org/10.1111/bjd.12532">Publisher Full Text </a></span></li><li><a name=ref-93 class=n-a></a><span class=label>93. </span>&nbsp;<span class=citation><a name=d12294e3044 class=n-a></a>Sahni K, Parsad D, Kanwar AJ, <i> et al.</i>: Autologous noncultured melanocyte transplantation for stable vitiligo: can suspending autologous melanocytes in the patients' own serum improve repigmentation and patient satisfaction? <i>Dermatol Surg.</i> 2011; <b>37</b>(2): 17682. <a target=xrefwindow id=d12294e3055 href="http://www.ncbi.nlm.nih.gov/pubmed/21269348">PubMed Abstract </a> | <a target=xrefwindow id=d12294e3058 href="http://dx.doi.org/10.1111/j.1524-4725.2010.01847.x">Publisher Full Text </a></span></li><li><a name=ref-94 class=n-a></a><span class=label>94. </span>&nbsp;<span class=citation><a name=d12294e3067 class=n-a></a>Sharquie KE, Noaimi AA, Al-Mudaris HA: Melanocytes transplantation in patients with vitiligo using needling micrografting technique. <i>J Drugs Dermatol.</i> 2013; <b>12</b>(5): e748. <a target=xrefwindow id=d12294e3075 href="http://www.ncbi.nlm.nih.gov/pubmed/23652963">PubMed Abstract </a></span></li><li><a name=ref-95 class=n-a></a><span class=label>95. </span>&nbsp;<span class=citation><a name=d12294e3084 class=n-a></a>Wassef C, Lombardi A, Khokher S, <i> et al.</i>: Vitiligo surgical, laser, and alternative therapies: a review and case series. <i>J Drugs Dermatol.</i> 2013; <b>12</b>(6): 68591. <a target=xrefwindow id=d12294e3095 href="http://www.ncbi.nlm.nih.gov/pubmed/23839187">PubMed Abstract </a></span></li><li><a name=ref-96 class=n-a></a><span class=label>96. </span>&nbsp;<span class=citation><a name=d12294e3105 class=n-a></a>Ghosh D, Kuchroo P, Viswanathan C, <i> et al.</i>: Efficacy and safety of autologous cultured melanocytes delivered on poly (DL-lactic acid) film: a prospective, open-label, randomized, multicenter study. <i>Dermatol Surg.</i> 2012; <b>38</b>(12): 198190. <a target=xrefwindow id=d12294e3116 href="http://www.ncbi.nlm.nih.gov/pubmed/23025333">PubMed Abstract </a> | <a target=xrefwindow id=d12294e3119 href="http://dx.doi.org/10.1111/dsu.12000">Publisher Full Text </a></span></li><li><a name=ref-97 class=n-a></a><span class=label>97. </span>&nbsp;<span class=citation><a name=d12294e3128 class=n-a></a>Huggins RH, Henderson MD, Mulekar SV, <i> et al.</i>: Melanocyte-keratinocyte transplantation procedure in the treatment of vitiligo: the experience of an academic medical center in the United States. <i>J Am Acad Dermatol.</i> 2012; <b>66</b>(5): 78593. <a target=xrefwindow id=d12294e3139 href="http://www.ncbi.nlm.nih.gov/pubmed/21864935">PubMed Abstract </a> | <a target=xrefwindow id=d12294e3142 href="http://dx.doi.org/10.1016/j.jaad.2011.05.002">Publisher Full Text </a></span></li></ul></div></div></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 06 Sep 2016</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/5-2234/v1&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/5-2234/v1&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> <div class="f1r-article-mobile margin-bottom-30"> <div class=contracted-details> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> The Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York, NY, 10016, USA<br/> <p> </p> </div> </div> <div class=contracted-details> <a href="#" class=section-title>Article Versions (1)</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> <div> <a href="https://f1000research.com/articles/5-2234/v1" title="Open version 1 of this article." class="" gahelper=1>version 1</a> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div> Published: 06 Sep 2016, 5:2234 </div> <div class=""><a href="https://doi.org/10.12688/f1000research.8976.1">https://doi.org/10.12688/f1000research.8976.1</a></div> </div> </div> <div class=contracted-details> <a href="#" class=section-title> <span class="f1r-icon icon-100_open_access"></span> Copyright </a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden">  2016 Manga P <em>et al</em>. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </div> </div> <div class="padding-top-30 research-layout"> <div class=article-toolbox-wrapper-mobile> <div class=article-tools-icon-mobile data-section=download> <span class="f1r-icon icon-76_download_file white"></span> </div> <div class="article-tools-icon-mobile mobile-metrics article-metrics-wrapper metrics-icon-wrapper" data-section=metrics data-version-id=9656 data-id=8976 data-downloads="" data-views="" data-scholar="10.12688/f1000research.8976.1" data-recommended="" data-f1r-ga-helper="Article Page Metrics (Mobile)"> <span class="f1r-icon icon-89_metrics white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=cite> <span class="f1r-icon icon-82_quote white"></span> </div> <div class="article-tools-icon-mobile " data-section=track> <span class="f1r-icon icon-90_track white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=share> <span class="f1r-icon icon-34_share white"></span> </div> <span class=article-toolbox-stretch></span> </div> <div class=article-toolbox-content-mobile> <div class="toolbox-section download"> <div class=toolbox-section-heading>Download</div> <div class=toolbox-section-content> <a href="https://f1000research.com/articles/5-2234/v1/pdf?article_uuid=71c621c6-08ce-4004-8ebe-460f2839e177" title="Download PDF" class="no-decoration pdf-download-helper"> <span class="f1r-icon icon-102_download_pdf toolbox-section-icon"></span> </a> <div class=toolbox-section-option-divider>&nbsp;</div> <a id=mobile-download-xml class=no-decoration href="#" title="Download XML"> <span class="f1r-icon icon-103_download_xml toolbox-section-icon"></span> </a> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>Export To</div> <div class=toolbox-section-content> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=WORKSPACE>Sciwheel</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=BIBTEX>Bibtex</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=ENDNOTE>EndNote</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=PROCITE>ProCite</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=REF_MANAGER>Ref. Manager (RIS)</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=SENTE>Sente</button> </div> </div> <div class="toolbox-section metrics"> <div class="toolbox-section-heading no-top-border">metrics</div> <div class="toolbox-section-divider toolbox-section-divider--no-height"></div> <div class=article-metrics-pageinfo> <div class=c-article-metrics-table> <table class=c-article-metrics-table__table> <thead> <tr> <th></th> <th><span class=c-article-metrics-table__heading>Views</span></th> <th><span class=c-article-metrics-table__heading>Downloads</span></th> </tr> </thead> <tbody> <tr> <th class=c-article-metrics-table__row-heading><span class="c-article-metrics-table__platform u-platform--" data-test-id=metrics_platform_name_mob>F1000Research</span></th> <td class="c-article-metrics-table__value js-article-views-count" data-test-id=metrics_platform_views_mob>-</td> <td class="c-article-metrics-table__value js-article-downloads-count" data-test-id=metrics_platform_downloads_mob>-</td> </tr> <tr> <th class=c-article-metrics-table__row-heading> <span class="u-ib u-middle c-article-metrics-table__pmc" data-test-id=metrics_pmc_name_mob>PubMed Central</span> <div class="c-block-tip c-block-tip--centered c-article-metrics-table__tooltip c-block-tip--md-padding c-block-tip--small-arrow u-ib u-middle"> <button type=button class="u-black--medium u-black--high@hover u-ib u-middle c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content>Data from PMC are received and updated monthly.</div> </div> </th> <td class="c-article-metrics-table__value js-pmc-views-count" data-test-id=metrics_pmc_views_mob>-</td> <td class="c-article-metrics-table__value js-pmc-downloads-count" data-test-id=metrics_pmc_downloads_mob>-</td> </tr> </tbody> </table> </div> </div> <span class=metrics-citations-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-heading u-mb--1">Citations</div> <div> <div class=toolbox-section-colsplit> <div class=citations-scopus-logo> <a href="" target=_blank class="is-hidden metrics-citation-icon" title="View full citation details at www.scopus.com"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count scopus"> <a href='' class='scopus-citation-link is-hidden' target=_blank title='View full citation details at www.scopus.com'>0</a> </div> </div> <div class=toolbox-section-colsplit> <div class="citations-pubmed-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon f1000research" title="View full citation details"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count pubmed"> <a href='' class='pubmed-citation-link is-hidden' target=_blank title='View full citation details'>0</a> </div> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <div class="citations-scholar-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon google-scholar f1000research" title="View full citation details" data-scholar="10.12688/f1000research.8976.1"><i class="material-icons scopus-icon">open_in_new</i></a> </div> </div> </div> </span> <span class=metrics-details-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-content altmetric-section"> <div class=altmetrics-image></div> <div class=altmetrics-more-link> <a href="" target=_blank class=f1r-standard-link>SEE MORE DETAILS</a> </div> <div class=altmetric-mobile-column-counts></div> <div class=altmetric-mobile-column-readers></div> <div class=toolbox-section-divider></div> </div> </span> </div> <div class="toolbox-section cite"> <div class="toolbox-section-heading no-top-border">CITE</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>how to cite this article</div> <div id=citation-copy-mobile class="toolbox-section-content text-content heading9 small" data-test-id=mob_copy-citation_text> Manga P, Elbuluk N and Orlow SJ. Recent advances in understanding vitiligo [version 1; peer review: 3 approved] <i>F1000Research</i> 2016, <b>5</b>(F1000 Faculty Rev):2234 (<a href="https://doi.org/10.12688/f1000research.8976.1" target=_blank>https://doi.org/10.12688/f1000research.8976.1</a>) </div> <div class=toolbox-section-divider></div> <div class="toolbox-section-content text-content heading9 small"> NOTE: <em>it is important to ensure the information in <b>square brackets after the title</b> is included in all citations of this article.</em> </div> <div class=toolbox-section-content> <button class="primary orange extra-padding copy-cite-article-mobile js-clipboard" data-clipboard-target="#citation-copy-mobile" title="Copy the current citation details." data-test-id=mob_copy-citation_button-mob>COPY CITATION DETAILS</button> </div> </div> <div class="toolbox-section track"> <div class="toolbox-section-heading no-top-border">track</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>receive updates on this article</div> <div class="toolbox-section-content padding-left-20 padding-right-20 heading9 small"> Track an article to receive email alerts on any updates to this article. </div> <div class=toolbox-section-content> <a data-article-id=8976 id=mobile-track-article-signin-8976 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/8976?target=/articles/5-2234/v1"> <button class="primary orange extra-padding"> TRACK THIS ARTICLE </button> </a> </div> </div> <div class="toolbox-section share"> <div class="toolbox-section-heading no-top-border">Share</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <a target=_blank class="f1r-shares-icon-square f1r-shares-email" title="Email this article"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-twitter" title="Share on Twitter"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-facebook" title="Share on Facebook"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-linkedin" title="Share on LinkedIn"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-reddit" title="Share on Reddit"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-mendelay" title="Share on Mendeley"></a> <div class="email-article-wrapper email-article-version-container"> <div class=toolbox-section-divider></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form-mobile research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=9656 /> <input name=articleId type=hidden value=8976 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> </div> </div> </div> <a name=article-reports></a> <div id=article-reports class="u-mt--3 reports-comments no-divider"> <div class="current-referee-status current-referee-status--faculty "> <h2 class=main-title id=current-referee-status> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-85_peer_review size30"></span> </span> Open Peer Review <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> <a name=current-referee-status></a> <div class=current-referee-status__content name=add-new-report-comment id=add-new-report-comment> Current Reviewer Status: <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile"> <div class=mobile-ref-status-help> Key to Reviewer Statuses <span class=referee-status-pointer></span> <span class="view-control float-right">VIEW</span> <span class="view-control float-right is-hidden">HIDE</span> <div class=mobile-ref-status-help-content> <div class="cf margin-top"> <span class="f1r-icon icon-86_approved status-green smaller float-left margin-bottom-40 margin-right" title=Approved></span> <span class=title>Approved</span>The paper is scientifically sound in its current form and only minor, if any, improvements are suggested </div> <div class="cf margin-top"> <span class="f1r-icon icon-87_approved_reservations status-green smaller float-left margin-bottom-40 margin-right" title="Approved with Reservations"></span> <span class=title>Approved with reservations</span> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </div> <div class="cf margin-top"> <span class="f1r-icon icon-88_not_approved status-red small float-left margin-bottom-30 margin-right" title="Not Approved"></span> <span class=title>Not approved</span>Fundamental flaws in the paper seriously undermine the findings and conclusions </div> </div> </div> </span> <div class=editorial-note> <h5 class=editorial-note__title>Editorial Note on the Review Process</h5> <p class=editorial-note__text><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home">Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> </div> <div class=approved-referee> <h4 class=approved-referee__title>Reviewers who approved this article</h4> <ol class=approved-referee__list> <li class="approved-referee__list-item "> <span class=approved-referee__co-referee> <strong>Stanca A. Birlea</strong>, Department of Dermatology and Human Medical Genetics Program, University of Colorado Anschutz Medical Campus, School of Medicine, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Gisela Erf</strong>, Division of Agriculture, Center of Excellence for Poultry Science, University of Arkansas, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>John E. Harris</strong>, Department of Medicine, Division of Dermatology, University of Massachusetts Medical School, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> </ol> </div> </div> </div> </div> <div class="f1r-article-mobile research-layout"> <div class="mobile-sections-divider before-comments"></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 06 Sep 2016</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/5-2234/v1&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/5-2234/v1&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> </div> </div> <div id=article_main-column class="p-article__sidebar o-layout__item u-1/3 not-expanded js-article-sidebar"> <div class="o-tab p-article__column-toggle-container"> <button class="c-tab c-tab--left js-column-toggle p-article__column-toggle not-expanded " type=button data-target-main=article_main-column data-target-secondary=article_secondary-column><i class="c-tab__icon material-icons u-hide@expanded">keyboard_arrow_left</i><i class="c-tab__icon material-icons u-show@expanded">keyboard_arrow_right</i></button> </div> <div class=p-article__sidebar-content> <div class="p-article__sidebar-scroller js-article-sidebar-scroller"> <section class="p-article__sidebar-view js-article-sidebar-view js-article-sidebar-main u-pt u-pb--8" data-view=peer-review> <div class="o-layout o-layout--flush"> <div class="o-layout__item u-pl"> <h3 class="u-mt--0 u-mb--2 t-h3 u-weight--md u-pl" data-test-id=article_sidebar_heading>Open Peer Review</h3> </div> <div class=o-layout__item> <section class=""> <div class="p-article__sidebar-highlight u-mb--2 u-pr--1"> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md u-mr--1/2">Reviewer Status</h4> <div class="c-referee-status__icons u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=15346-16120></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=15347-16122></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=15339-16121></i> </div> </div> <div class="o-actions__secondary _mdl-layout"> <div class="c-block-tip p-article__sidebar-tooltip c-block-tip--below c-block-tip--small-arrow c-block-tip--sm-padding"> <button type=button class="c-button c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content> <p class="t-body u-mt--0 u-mb--0"><em class=u-weight--md>Alongside their report, reviewers assign a status to the article:</em></p> <dl class=c-definitions> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved</span></dt> <dd class="c-definitions__description t-caption">The paper is scientifically sound in its current form and only minor, if any, improvements are suggested</dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--reservations" title="Approved with Reservations" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved with reservations</span></dt> <dd class="c-definitions__description t-caption"> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--not-approved " title="Not Approved" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Not approved</span></dt> <dd class="c-definitions__description t-caption">Fundamental flaws in the paper seriously undermine the findings and conclusions</dd> </dl> </div> </div> </div> </div> </div> <div class="o-layout__item u-mb--1"><h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md">Reviewer Reports</h4></div> <table class="c-report-timeline u-mb--2"> <thead class=c-report-timeline__headings> <tr> <th></th> <th class="u-pb--1/2" colspan=3><em class="t-body u-weight--rg">Invited Reviewers</em></th> </tr> <tr class=c-report-timeline__headings-row> <th></th> <th class="c-report-timeline__headings-version p-article__color--dark">1</th> <th class="c-report-timeline__headings-version p-article__color--dark">2</th> <th class="c-report-timeline__headings-version p-article__color--dark">3</th> </tr> </thead> <tbody> <tr class="c-report-timeline__row c-report-timeline__row--selected "> <th class=c-report-timeline__version> <a data-test-id=sidebar_timeline_v1_version href="https://f1000research.com/articles/5-2234/v1">Version 1</a><br/> <span class=p-article__color--dark> <span data-test-id=sidebar_timeline_v1_date class=c-report-timeline__date>06 Sep 16</span> </span> </th> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> </tr> </tbody> </table> <div class=o-layout__item> <hr class="c-hr c-hr--low u-mb--2"> </div> </section> </div> <div class=o-layout__item> <div class="u-pl u-pr"> <p class="t-body u-mt--0 u-mb--2"><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home" target=_blank class=in-text-link>Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> <ol class="p-article__faculty-referee-list t-caption"> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Stanca A. Birlea</strong>, Department of Dermatology and Human Medical Genetics Program, University of Colorado Anschutz Medical Campus, School of Medicine, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Gisela Erf</strong>, Division of Agriculture, Center of Excellence for Poultry Science, University of Arkansas, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>John E. Harris</strong>, Department of Medicine, Division of Dermatology, University of Massachusetts Medical School, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> </ol> </div> </div> <section class="o-layout__item u-pl"> <div class=u-pl> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--2">Comments on this article</h4> <div class=u-mb--4> <p class="u-mt--0 u-mb--1 t-h4"><a class=p-article__color--light href="#article-comments">All Comments</a><span class=" u-ib u-ml--1/2 p-article__color--light">(0)</span></p> <a class=t-h4 href="/login?originalPath=/articles/5-2234/v1&scrollTo=add-new-comment" data-test-id=add-comment>Add a comment</a> </div> <hr class="c-hr c-hr--low c-hr--md u-mb--4"> <div class="research-layout f1r-article-desk"> <div class="heading6 c-ribbon-wrapper c-ribbon-wrapper--etoc f1000research "> <div class=c-ribbon-wrapper__body>Sign up for content alerts</div> </div> </div> <div class="research-layout sidebar-sign-up-form f1r-article-desk u-mb--4 "> <form class=js-email-alert-signup action="#" method=POST data-email=tocAlertWeekly> <input type=hidden name=isUserLoggedIn class=js-email-alert-signup-logged-in value=N /> <input type=hidden name=userId class=js-email-alert-signup-user-id value=""/> <input type=hidden name=frequency class=js-email-alert-signup-frequency value=WEEKLY /> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <input type=email name=emailAddress class="form-input-field js-email-alert-signup-address u-1/1 u-bb" required=required placeholder=Email /> </div> <div class=o-actions__secondary> <div class="_mdl-layout u-ml--1/2"> <button class="mdl-button mdl-js-button mdl-button--colored mdl-button--small mdl-button--filled js-email-alert-signup-submit">Sign Up</button> </div> </div> </div> </form> <div id=sidebar-sign-up-message class="section-text js-email-alert-signup-msg is-hidden">You are now signed up to receive this alert</div> </div> <section class=js-terms-container> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--1">Browse by related subjects</h4> <div class="article-subcontainer article-subcontainer--sidebar"> <ul class=js-terms-list></ul> </div> </section> </div> </section> </div> </section> </div> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/read-more.js"></script> <script src="/js/article/article-router.js"></script> <script src="/js/article/article-sidebar.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/article/article-column-toggle.js"></script> </div> </div> </div> </main> <input type=hidden id=_articleVersionUrl value="https://f1000research.com/articles/5-2234/v1/"> <div class=research-help id=about-referee-status> <div class="research-layout research-help-content about-referee-status"> <span class="close-research-help dark-cross" title=Close></span> Alongside their report, reviewers assign a status to the article: <div class="cf research-help-row"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> <span class=research-help-text>Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested</span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-87_approved_reservations status-green smaller" title="Approved with Reservations"></span> <span class=research-help-text>Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-88_not_approved status-red small" title="Not Approved"></span> <span class=research-help-text>Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions</span> </div> </div> </div> <div id=datasets-info class=is-hidden> </div> <div class=article-interactive-content-container style="display: none;"> <a name=f-template class=n-a></a> <div class="interactive-content-wrapper padding-20"> <img src="" class=interactive-content-image title="Open the interactive image display"> <div class=interactive-content-title></div> <div class=interactive-content-text></div> <div class="f1r-article-desk interactive-content-ribbon" data-interactive-content-type=R-Script> <div class=interactive-content-label>Adjust parameters to alter display</div> <div class=interactive-content-button></div> </div> <div class="f1r-article-mobile mobile-interactive-note"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div id=article-interactive-omero-container class=article-interactive-omero-container style="display: none;"> <div class=interactive-content-wrapper> <div class="interactive-omero-button omero-content" title="Open the interactive content window." data-interactive-content-type=Omero></div> <div class=has-interactive-content-image> <span class=box-arrow></span> <span class=box-middle>Includes Interactive Elements</span> <span class=box-end></span> </div> <div class="fig panel clearfix" style="margin: 0; padding-bottom: 20px;"> <a name=templatelink class=n-a></a> <a target=_blank href="" class=link-for-omero-image> <img src="" class=interactive-omero-image title="Open the image display window."> </a> <div class=caption> <div class=interactive-content-title></div> <div class=interactive-content-text></div> </div> <div class="is-hidden omero-image-list"></div> </div> <div class="f1r-article-mobile mobile-interactive-note omero"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div class="add-comment-container shadow-box is-hidden" id=save-comment-container> <span id=save-comment-text class=intro-text>Edit comment</span> <textarea id=new-comment name=new-comment class="global-textarea comment margin-bottom margin-top"></textarea> <p><strong>Competing Interests</strong></p> <textarea id=new-competing-interests name=competing-interests class="global-textarea competing-interests margin-bottom check-xss"></textarea> <div class=clearfix></div> <button id=cancelComment type=button class="general-white-orange-button float-right no-background-button margin-left"> Cancel </button> <button id=save-comment-button commentId="" type=button class="general-white-orange-button float-right"> Save </button> <div class=clearfix></div> <div class="green-message margin-top is-hidden comment-is-saved">The comment has been saved.</div> <div class="red-message margin-top is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class="red-message margin-top is-hidden comment-enter-text ucf">Your must enter a comment.</div> <div class="red-message margin-top is-hidden comment-references-error references">References error.</div> </div> <div class="modal-window-wrapper is-hidden"> <div id=conflicts-interests class="modal-window padding-20"> <div class=modal-window__content> <h2 class=h2-title>Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div class="f1r-article-mobile research-layout"> <span class=modal-window-close-button></span> </div> </div> </div> <div class="o-modal c-email-alert-popup js-email-alert-popup is-hidden"> <div class="o-modal__body js-modal-body c-email-alert-popup__inner"> <h3 class=c-email-alert-popup__title>Stay Updated</h3> <p class=c-email-alert-popup__sub>Sign up for content alerts and receive a weekly or monthly email with all newly published articles</p> <p><a href="/register?originalPath=" class="c-email-alert-popup__lnk c-email-alert-popup__button js-email-alert-popup-action">Register with F1000Research</a></p> <p>Already registered? <a href="/login?originalPath=" class="c-email-alert-popup__lnk js-email-alert-popup-action">Sign in</a></p> <p class=c-email-alert-popup__footer><a class="c-email-alert-popup__lnk js-email-alert-popup-cancel" href="#">Not now, thanks</a></p> </div> </div> <div id=addCommentModal role=dialog aria-labelledby=addCommentModal_title aria-describedby=addCommentModal_description> <div class="c-modal js-modal is-closed p-article__add-comment-modal c-modal--xlarge js-article-comment-modal c-modal--scroll "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-bg--2 c-modal--scroll-always "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <div id=addCommentModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div class="js-add-comment-container t-caption u-black--high"> <div class=u-weight--bd>PLEASE NOTE</div> <div class=u-mt--1> <span class="red u-weight--bd">If you are an AUTHOR of this article,</span> please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a &ldquo;User Comment&rdquo;. </div> <div class=u-mt--1> <span class="red u-weight--bd">If you are a REVIEWER of this article,</span> please check that you have signed in with the account associated with this article and then go to your <a href="/my/referee">account</a> to submit your report, please do not post your review here. </div> <div class="u-mt--1 u-mb--1"> If you do not have access to your original account, please <a href="mailto:research@f1000.com">contact us</a>. </div> <p class=no-top-margin>All commenters must hold a formal affiliation as per our <a href="/about/policies#commentspolicy" target=_blank>Policies</a>. The information that you give us will be displayed next to your comment.</p> <p>User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the <a href="/about/legal/usercommenttermsandconditions" target=_blank>User Comment Terms and Conditions</a>. Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available.</p> <div class="comments-note margin-bottom" id=accept-user-comments> <input class=js-add-comment-accept-terms type=checkbox id=acceptedTermsAndConditions name=acceptedTermsAndConditions> I accept the <a href="/about/legal/usercommenttermsandconditions" target=_blank> User Comment Terms and Conditions</a> <span class=required>&nbsp;</span> </div> <div class="default-error margin-top is-hidden comment-accept-conditions utac">Please confirm that you accept the User Comment Terms and Conditions.</div> <div class="research-layout registration-form u-mb--2"> <div class="u-mb--1 u-mt--2"> <strong>Affiliation</strong> </div> <div class=form-field> <input type=text name=institution class="form-input-field check-xss js-add-comment-institution" placeholder="Organization *" autocomplete=off /> <div class="default-error margin-top is-hidden comment-enter-institution institution">Please enter your organisation.</div> </div> <div class=form-field> <input type=text name=place class="form-input-field check-xss js-add-comment-place" placeholder=Place> </div> <div class=form-field> <div class="form-input-wrapper hundred-percent-wide"> <div class="new-select-standard-wrapper half-width inline-display heading10"> <select name=countryId id=country class="form-select-menu smaller js-add-comment-country"> <option value=-1>Country*</option> <option value=840>USA</option> <option value=826>UK</option> <option value=124>Canada</option> <option value=156>China</option> <option value=250>France</option> <option value=276>Germany</option> <optgroup label=-----------------------------------------------></optgroup> <option value=4>Afghanistan</option> <option value=248>Aland Islands</option> <option value=8>Albania</option> <option value=12>Algeria</option> <option value=16>American Samoa</option> <option value=20>Andorra</option> <option value=24>Angola</option> <option value=660>Anguilla</option> <option value=10>Antarctica</option> <option value=28>Antigua and Barbuda</option> <option value=32>Argentina</option> <option value=51>Armenia</option> <option value=533>Aruba</option> <option value=36>Australia</option> <option value=40>Austria</option> <option value=31>Azerbaijan</option> <option value=44>Bahamas</option> <option value=48>Bahrain</option> <option value=50>Bangladesh</option> <option value=52>Barbados</option> <option value=112>Belarus</option> <option value=56>Belgium</option> <option value=84>Belize</option> <option value=204>Benin</option> <option value=60>Bermuda</option> <option value=64>Bhutan</option> <option value=68>Bolivia</option> <option value=70>Bosnia and Herzegovina</option> <option value=72>Botswana</option> <option value=74>Bouvet Island</option> <option value=76>Brazil</option> <option value=86>British Indian Ocean Territory</option> <option value=92>British Virgin Islands</option> <option value=96>Brunei</option> <option value=100>Bulgaria</option> <option value=854>Burkina Faso</option> <option value=108>Burundi</option> <option value=116>Cambodia</option> <option value=120>Cameroon</option> <option value=124>Canada</option> <option value=132>Cape Verde</option> <option value=136>Cayman Islands</option> <option value=140>Central African Republic</option> <option value=148>Chad</option> <option value=152>Chile</option> <option value=156>China</option> <option value=162>Christmas Island</option> <option value=166>Cocos (Keeling) Islands</option> <option value=170>Colombia</option> <option value=174>Comoros</option> <option value=178>Congo</option> <option value=184>Cook Islands</option> <option value=188>Costa Rica</option> <option value=384>Cote d'Ivoire</option> <option value=191>Croatia</option> <option value=192>Cuba</option> <option value=196>Cyprus</option> <option value=203>Czech Republic</option> <option value=180>Democratic Republic of the Congo</option> <option value=208>Denmark</option> <option value=262>Djibouti</option> <option value=212>Dominica</option> <option value=214>Dominican Republic</option> <option value=218>Ecuador</option> <option value=818>Egypt</option> <option value=222>El Salvador</option> <option value=226>Equatorial Guinea</option> <option value=232>Eritrea</option> <option value=233>Estonia</option> <option value=231>Ethiopia</option> <option value=238>Falkland Islands</option> <option value=234>Faroe Islands</option> <option value=583>Federated States of Micronesia</option> <option value=242>Fiji</option> <option value=246>Finland</option> <option value=250>France</option> <option value=254>French Guiana</option> <option value=258>French Polynesia</option> <option value=260>French Southern Territories</option> <option value=266>Gabon</option> <option value=268>Georgia</option> <option value=276>Germany</option> <option value=288>Ghana</option> <option value=292>Gibraltar</option> <option value=300>Greece</option> <option value=304>Greenland</option> <option value=308>Grenada</option> <option value=312>Guadeloupe</option> <option value=316>Guam</option> <option value=320>Guatemala</option> <option value=831>Guernsey</option> <option value=324>Guinea</option> <option value=624>Guinea-Bissau</option> <option value=328>Guyana</option> <option value=332>Haiti</option> <option value=334>Heard Island and Mcdonald Islands</option> <option value=336>Holy See (Vatican City State)</option> <option value=340>Honduras</option> <option value=344>Hong Kong</option> <option value=348>Hungary</option> <option value=352>Iceland</option> <option value=356>India</option> <option value=360>Indonesia</option> <option value=364>Iran</option> <option value=368>Iraq</option> <option value=372>Ireland</option> <option value=376>Israel</option> <option value=380>Italy</option> <option value=388>Jamaica</option> <option value=392>Japan</option> <option value=832>Jersey</option> <option value=400>Jordan</option> <option value=398>Kazakhstan</option> <option value=404>Kenya</option> <option value=296>Kiribati</option> <option value=901>Kosovo (Serbia and Montenegro)</option> <option value=414>Kuwait</option> <option value=417>Kyrgyzstan</option> <option value=418>Lao People's Democratic Republic</option> <option value=428>Latvia</option> <option value=422>Lebanon</option> <option value=426>Lesotho</option> <option value=430>Liberia</option> <option value=434>Libya</option> <option value=438>Liechtenstein</option> <option value=440>Lithuania</option> <option value=442>Luxembourg</option> <option value=446>Macao</option> <option value=807>Macedonia</option> <option value=450>Madagascar</option> <option value=454>Malawi</option> <option value=458>Malaysia</option> <option value=462>Maldives</option> <option value=466>Mali</option> <option value=470>Malta</option> <option value=584>Marshall Islands</option> <option value=474>Martinique</option> <option value=478>Mauritania</option> <option value=480>Mauritius</option> <option value=175>Mayotte</option> <option value=484>Mexico</option> <option value=581>Minor Outlying Islands of the United States</option> <option value=498>Moldova</option> <option value=492>Monaco</option> <option value=496>Mongolia</option> <option value=499>Montenegro</option> <option value=500>Montserrat</option> <option value=504>Morocco</option> <option value=508>Mozambique</option> <option value=104>Myanmar</option> <option value=516>Namibia</option> <option value=520>Nauru</option> <option value=524>Nepal</option> <option value=530>Netherlands Antilles</option> <option value=540>New Caledonia</option> <option value=554>New Zealand</option> <option value=558>Nicaragua</option> <option value=562>Niger</option> <option value=566>Nigeria</option> <option value=570>Niue</option> <option value=574>Norfolk Island</option> <option value=580>Northern Mariana Islands</option> <option value=408>North Korea</option> <option value=578>Norway</option> <option value=512>Oman</option> <option value=586>Pakistan</option> <option value=585>Palau</option> <option value=275>Palestinian Territory</option> <option value=591>Panama</option> <option value=598>Papua New Guinea</option> <option value=600>Paraguay</option> <option value=604>Peru</option> <option value=608>Philippines</option> <option value=612>Pitcairn</option> <option value=616>Poland</option> <option value=620>Portugal</option> <option value=630>Puerto Rico</option> <option value=634>Qatar</option> <option value=638>Reunion</option> <option value=642>Romania</option> <option value=643>Russian Federation</option> <option value=646>Rwanda</option> <option value=654>Saint Helena</option> <option value=659>Saint Kitts and Nevis</option> <option value=662>Saint Lucia</option> <option value=666>Saint Pierre and Miquelon</option> <option value=670>Saint Vincent and the Grenadines</option> <option value=882>Samoa</option> <option value=674>San Marino</option> <option value=678>Sao Tome and Principe</option> <option value=682>Saudi Arabia</option> <option value=686>Senegal</option> <option value=688>Serbia</option> <option value=690>Seychelles</option> <option value=694>Sierra Leone</option> <option value=702>Singapore</option> <option value=703>Slovakia</option> <option value=705>Slovenia</option> <option value=90>Solomon Islands</option> <option value=706>Somalia</option> <option value=710>South Africa</option> <option value=239>South Georgia and the South Sandwich Is</option> <option value=410>South Korea</option> <option value=724>Spain</option> <option value=144>Sri Lanka</option> <option value=736>Sudan</option> <option value=740>Suriname</option> <option value=744>Svalbard and Jan Mayen</option> <option value=748>Swaziland</option> <option value=752>Sweden</option> <option value=756>Switzerland</option> <option value=760>Syria</option> <option value=158>Taiwan</option> <option value=762>Tajikistan</option> <option value=834>Tanzania</option> <option value=764>Thailand</option> <option value=270>The Gambia</option> <option value=528>The Netherlands</option> <option value=626>Timor-Leste</option> <option value=768>Togo</option> <option value=772>Tokelau</option> <option value=776>Tonga</option> <option value=780>Trinidad and Tobago</option> <option value=788>Tunisia</option> <option value=792>Turkey</option> <option value=795>Turkmenistan</option> <option value=796>Turks and Caicos Islands</option> <option value=798>Tuvalu</option> <option value=800>Uganda</option> <option value=826>UK</option> <option value=804>Ukraine</option> <option value=784>United Arab Emirates</option> <option value=850>United States Virgin Islands</option> <option value=858>Uruguay</option> <option value=840>USA</option> <option value=860>Uzbekistan</option> <option value=548>Vanuatu</option> <option value=862>Venezuela</option> <option value=704>Vietnam</option> <option value=876>Wallis and Futuna</option> <option value=905>West Bank and Gaza Strip</option> <option value=732>Western Sahara</option> <option value=887>Yemen</option> <option value=894>Zambia</option> <option value=716>Zimbabwe</option> </select> </div> </div> <div class="default-error margin-top is-hidden comment-enter-country country">Please select your country.</div> </div> </div> <textarea data-test-id=article_add-comment_comment name=new-comment class="js-add-comment-comment comment margin-bottom margin-top"></textarea> <div class="default-error margin-top comment-enter-text comment-error is-hidden ">You must enter a comment.</div> <label class="comments-note u-mt--2 u-mb--2" for=competingInterests_1> <div class="u-mb--1 u-mt--2"><strong data-test-id=article_report-add-comment_competing-interests-title>Competing Interests</strong></div> <p class="u-mb--2 u-mt--0" data-test-id=article_report-add-comment_competing-interests-description>Please disclose any <a href="#article-competing-intersts-policy" class=js-modal-competing-intersts-toggle>competing interests</a> that might be construed to influence your judgment of the article's or peer review report's validity or importance.</p> </label> <div id=article-competing-intersts-policy class=js-article-competing-interests-policy style="display: none;"> <h2 class="h2-title u-mt--0 u-pt--0">Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div id=competingInterests_1 class="c-inline-editor js-inline-editor js-form_input u-bb--all u-mb--2 js-comment-competing-interests" data-name=competing-interests data-rows=3> <textarea id=competingInterests_1_input name=competing-interests placeholder="&nbsp;" required=false class="u-hide-visually js-inline-editor_input" tabindex=-1></textarea> <div class="c-inline-editor__editor js-inline-editor_editor o-box c-box o-box--tiny u-bg--11" data-target=competingInterests_1_input role=textbox required=false data-placeholder="&nbsp;" contenteditable=true></div> <span class="c-inline-editor__error js-inline-editor-message">Please state your competing interests</span> </div> <div data-test-id=article_add-comment_saved class="green-message comments is-hidden comment-is-saved">The comment has been saved.</div> <div data-test-id=article_add-comment_error class="default-error comments is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class=clearfix></div> <div class=js-hook></div> </div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" data-test-id=article_add-comment_cancel class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" data-test-id=article_add-comment_post class="c-button c-button--full js-modal__confirm c-button--primary">Post</a> </div> </aside> </div> </div> <style>
                .at-icon-wrapper {
        background-size: 100% !important;
    }
</style> <script src="/js/namespace.js"></script> <script src="/js/constants.js"></script> <script src="/js/utilities.js"></script> <script src="/js/article/alert-signup.js"></script> <script type='text/javascript'>
    var lTitle = "Recent advances in understanding vitiligo".replace("'", '');
    var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/5-2234/v1" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by ');

    var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/5-2234/v1&title=" + encodeURIComponent(lTitle);

    var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/5-2234/v1" + "&title=" + encodeURIComponent(lTitle);

            linkedInUrl += encodeURIComponent('Manga P et al.');
    
    var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; 
    var addthis_config = {
            ui_offset_top: offsetTop,
                                    services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_custom : [
                {
                    name: "LinkedIn",
                    url:  linkedInUrl,
                    icon:"/img/icon/at_linkedin.svg"
                },
                {
                    name: "Mendeley",
                    url:  "http://www.mendeley.com/import/?url=https://f1000research.com/articles/5-2234/v1/mendeley",
                    icon:"/img/icon/at_mendeley.svg"
                },
                {
                    name: "Reddit",
                    url:  redditUrl,
                    icon:"/img/icon/at_reddit.svg"
                },
            ]
        };


    var addthis_share = {
            url: "https://f1000research.com/articles/5-2234",
            templates : {
                twitter : "Recent advances in understanding vitiligo. Manga P et al., published by " + 
               "@F1000Research"
       + ", https://f1000research.com/articles/5-2234/v1"
            }
        };

    if (typeof(addthis) != "undefined"){
        addthis.addEventListener('addthis.ready', checkCount);
        addthis.addEventListener('addthis.menu.share', checkCount);
    }

        $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter);
    $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url);
    $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url);
    $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url);
    $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url);

    function checkCount(){
        setTimeout(function(){
            $(".addthis_button_expanded").each(function(){
                var count = $(this).text();
                if (count !== "" && count != "0")
                    $(this).removeClass("is-hidden");
                else
                    $(this).addClass("is-hidden");
            });
        }, 1000);
    }
</script> <div id=citeReportModal role=dialog aria-labelledby=citeReportModal_title aria-describedby=citeReportModal_description> <div class="c-modal js-modal is-closed c-modal--large js-cite-report-modal "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-black--high "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <h1 id=citeReportModal_title class="c-modal__title t-h3 u-mt--0 u-mb--2 u-weight--md">How to cite this report</h1> <div id=citeReportModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div id="" class=js-report-citation-container>{{reportCitation}}</div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" title="Copy the current citation details to the clipboard." data-clipboard-target="#referee-report-citation" data-test-id=report_copy-citation_button class="c-button c-button--full js-modal__confirm c-button--primary js-clipboard c-mini-tooltip--above">Copy Citation Details</a> </div> </aside> </div> </div> <script src="/js/referee/new/referee_validators.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/referee/new/referee_checkbox-input.js"></script> <script src="/js/referee/new/referee_inline-editor.js"></script> <script type="text/javascript">
    $(function(){
        var gaCat = "F1000Research";
        if (gaCat === "") {
            gaCat = $("body").hasClass("wellcome-brand") ? "Wellcome Open Research" : "F1000Research";
        }
        GAHelper.track({category: gaCat, action: "Article Page: Recent advances in understanding vitiligo", label: "pageviews"});
        GAHelper.track({category: gaCat, action: "Article Type: Review", label: "Article Page"});
        $(".f1r-article-desk .collection-image").each(function (idx, el) {
            var whatChannel = $(el).find("a").attr("href"),
                channelName = $.trim($(el).parent().find(".collection-detail a").text()),
                gaRef = "(ID: " + whatChannel.replace("/collections/", "") + ") " + channelName;
            GAHelper.track({category: 'ChannelStats', action: "Article Page: Recent advances in understanding vitiligo", label: gaRef});
        });
    });
</script> <script>
    $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');});
    $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');});
</script> <script src="/js/article/track_article.js" type="text/javascript"></script> <script type="text/javascript">
    $.get("/articles/acj/8976/9656")
</script> <script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script type="text/javascript" src="/js/app/messenger.js"></script> <script type="text/javascript" src="/js/article/article_mobiles.js"></script> <script src="/js/vendor/clipboard.min.js"></script> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/clipboard.js"></script> <script src="/js/article/thesaurus-terms-display.js"></script> <script>
    new F1000.Clipboard();
    new F1000.ThesaurusTermsDisplay("faculty-reviews", "article", "9656");
</script> <script>
    $(document).ready(function() {
        $( "#frame1" ).on('load', function() {
            var mydiv = $(this).contents().find("div");
            var h     = mydiv.height();
            console.log(h)
        });

        
        var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"),
            titleLivingFigure = tooltipLivingFigure.attr("title");
        tooltipLivingFigure.simpletip({
            fixed: true,
            position: ["-115", "30"],
            baseClass: 'small-tooltip',
            content:titleLivingFigure + "<div class='tooltip-arrow'></div>"
        });
        tooltipLivingFigure.removeAttr("title");

        $("body").on("click", ".cite-living-figure", function(e) {
            e.preventDefault();
            var ref = $(this).attr("data-ref");
            $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200);
        });
        $("body").on("click", ".close-cite-living-figure", function(e) {
            e.preventDefault();
            $(this).closest(".popup-window-wrapper").fadeOut(200);
        });

                $(document).on("mouseup", function(e) {
            var metricsContainer = $(".article-metrics-popover-wrapper");
            if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) {
                $(".article-metrics-close-button").click();
            }
        });

        var articleId = $('#articleId').val();

        if($("#main-article-count-box").attachArticleMetrics) {
            $("#main-article-count-box").attachArticleMetrics(articleId, {
                articleMetricsView: true
            });
        }
    });

    var figshareWidget = $(".new_figshare_widget");
    if (figshareWidget.length > 0) {
        window.figshare.load("f1000", function(Widget) {
            // Select a tag/tags defined in your page. In this tag we will place the widget.
            _.map(figshareWidget, function(el){
                var widget = new Widget({
                    articleId: $(el).attr("figshare_articleId")
                    //height:300 // this is the height of the viewer part. [Default: 550]
                });
                widget.initialize(); // initialize the widget
                widget.mount(el); // mount it in a tag that's on your page
                // this will save the widget on the global scope for later use from
                // your JS scripts. This line is optional.
                //window.widget = widget;
            });
        });
    }
</script>

<script>
    $(document).ready(function () {

        
        var reportIds = {
                           "16120": 0,
                           "16121": 0,
                           "16122": 0,
                    };

        $(".referee-response-container,.js-referee-report").each(function(index, el) {
            var reportId = $(el).attr("data-reportid"),
                reportCount = reportIds[reportId] || 0;
            $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount);
        });

        var uuidInput = $("#article_uuid"),
            oldUUId = uuidInput.val(),
            newUUId = "24be080c-295c-4fdd-90f4-9f3fc35dd034";
        uuidInput.val(newUUId);

        $("a[href*='article_uuid=']").each(function(index, el) {
            var newHref = $(el).attr("href").replace(oldUUId, newUUId);
            $(el).attr("href", newHref);
        });

    });
</script>              </div>
        </div>

        
            
            <div class="o-page__footer sticky-email-wrapper">
                
                

                


<footer class="c-footer t-inverted">

    <div class="o-wrapper">
        <div class="o-layout">


                        
            <div class="o-layout__item u-mb--3">
                <div class="c-branding c-branding--research">
                    <img src="/img/research/F1000Research_white.svg" alt="F1000Research">
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <p class="t-h3 u-mt--0 u-mb--0">An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing.</p>

            </div>


                        
            <div class="o-layout__item u-2/3@md">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <div class="o-layout">
                    <nav class="c-footer__nav">

                            <div class="o-layout__item u-3/5@sm u-mb--3">


                                <div class="o-columns o-columns--2">

                                                                            <a href="/browse/articles" class="t-body c-footer__nav-item "      >Browse</a>
                                                                            <a href="/gateways" class="t-body c-footer__nav-item "      >Gateways</a>
                                                                            <a href="/collections" class="t-body c-footer__nav-item "      >Collections</a>
                                                                            <a href="/about" class="t-body c-footer__nav-item "      >How it Works</a>
                                                                            <a href="https://blog.f1000.com/blogs/f1000research/" class="t-body c-footer__nav-item "      >Blog</a>
                                                                            <a href="/contact" class="t-body c-footer__nav-item "      >Contact</a>
                                                                            <a href="/developers" class="t-body c-footer__nav-item u-hide u-show@navbar"      >For Developers</a>
                                                                            <a href="/published/rss" class="t-body c-footer__nav-item "   title="RSS feed of published articles"     >RSS</a>
                                    
                                </div>

                            </div>

                            <div class="o-layout__item u-2/5@sm u-center u-right@sm u-mb--3">

                                <div class="u-hide u-show@lg">
                                    <div class="_mdl-layout">
                                        <a class="mdl-button mdl-js-button mdl-button--inverted mdl-button--no-shadow mdl-js-ripple-effect mdl-button--outline" href="/for-authors/publish-your-research"   data-test-id="footer_submit_research"  >Submit Your Research</a>
                                    </div>
                                </div>

                            </div>

                    </nav>
                </div>

            </div>

            <div class="o-layout__item u-mb--2">
                <div class="c-footer__share">
                        <div class="c-footer__share">
        <span class="c-footer__share-icon" title="Open Access">
            <span class="f1r-icon icon-100_open_access license-icon"></span>
        </span>

        <a class="c-footer__share-icon" href="//creativecommons.org/licenses" target="_blank" title="Creative Commons License CC-BY">
            <span class="f1r-icon icon-116_cc license-icon license-icon-cc"></span>
            <span class="f1r-icon icon-117_ccby license-icon license-icon-cc"></span>
        </a>

        <a class="c-footer__share-icon" href="//creativecommons.org/about/cc0" target="_blank" title="Creative Commons License CC0">
            <span class="f1r-icon icon-118_cco license-icon"></span>
        </a>

    </div>
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="c-footer__social u-mt--0 u-mb--0 u-white--low-med">Follow us
                    <a href="https://www.facebook.com/F1000" target="_blank" class="c-footer__social-icon f1r-icon icon-55_footer_facebook"></a>
                    <a href="https://twitter.com/#!/F1000Research" target="_blank" class="c-footer__social-icon f1r-icon icon-56_footer_twitter"></a>
                    <a href="http://www.youtube.com/user/F1000research" target="_blank" class="c-footer__social-icon f1r-icon icon-57_footer_youtube"></a></p>

            </div>


                        
            <div class="o-layout__item u-2/3@md u-right@md">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="t-caption u-white--low-med">&copy; 2012-2020 F1000 Research Ltd. ISSN 2046-1402 | <a href="/about/legal" class="copyrightLegal">Legal</a> | Partner of <a target="_blank" href="http://www.who.int/hinari/en/">HINARI</a>  &bull; <a target="_blank" href="http://crossref.org/">CrossRef</a> &bull; <a target="_blank" href="http://about.orcid.org/">ORCID</a> &bull; <a target="_blank" href="http://www.fairsharing.org">FAIRSharing</a></p>

            </div>
        </div>
    </div>

</footer>            </div>
        
    </div>

            <div class="js-cookie-spacer"></div>
        <div class="cookie-warning">
            <div class="instruction">The F1000Research website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. <a class="js-scroll-to" href="/about/legal/privacypolicy#use-of-cookies" data-scroll-target="#use-of-cookies">Find out more &raquo;</a></div>
            <div class="close-button"></div>
        </div>
    
    <script>
                    R.templateTests.simpleTemplate = R.template('<p class="$variable.one">$text</p><p class="${variable.two}">$text</p><p class="$!variable.three">$text</p><p class="$!{variable.four}">$text</p><p class="${selector}.five">$text</p>');
            R.templateTests.runTests();
        
        var F1000platform = new F1000.Platform({
            name: "f1000research",
            displayName: "F1000Research",
            hostName: "f1000research.com",
            id: "1",
            editorialEmail: "research@f1000.com",
            infoEmail: "info@f1000.com",
            usePmcStats: true
        });

                    $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');});
            // $(function(){R.ui.dropdowns('.dropdown-for-referees');});

            $(document).ready(function () {
                if ($(".cookie-warning").is(":visible")) {
                    $(".sticky").css("margin-bottom", "35px");
                    $(".devices").addClass("devices-and-cookie-warning");
                }
                $(".cookie-warning .close-button").click(function (e) {
                    $(".devices").removeClass("devices-and-cookie-warning");
                    $(".sticky").css("margin-bottom", "0");
                });

                $("#tweeter-feed .tweet-message").each(function (i, message) {
                    var self = $(message);
                    self.html(linkify(self.html()));
                });

                $(".partner").on("mouseenter mouseleave", function() {
                    $(this).find(".gray-scale, .colour").toggleClass("is-hidden");
                });
            });
        
    </script>

            
<div class="sign-in-popup">
	<!-- <a href="#" class="sign-in shadow">Sign in <span class="sign-in-image-active"></span></a> -->
	<a href="#" class="sign-in ${locale}">Sign In <span class="arrow-closed sign-in-arrow-padding arrow-opened"></span></a>
	<div class="sign-in-form">

            <form action="https://f1000research.com/j_spring_oauth_security_check" id="googleOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/5-2234.html"/>
                            <input id="google-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-google" name="system" type="hidden" value="GOOGLE"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="facebookOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/5-2234.html"/>
                            <input id="facebook-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-fb" name="system" type="hidden" value="FACEBOOK"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="orcidOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/5-2234.html"/>
                            <input id="orcid-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-orcid" name="system" type="hidden" value="ORCID"/>
    </form>
		<form id="sign-in-form" class="login-container" action="https://f1000research.com/login" method="post" name="f">
           <div id="sign-in-form-gfb-popup"></div>

                                                            <input class="target-field" type="hidden" name="target" value="/articles/5-2234.html"/>
                            			<input type="text" name="username" id="signin-email-box" class="sign-in-input" placeholder="Email address" autocomplete="email">
			<input type="password" name="password" id="signin-password-box" class="sign-in-input" placeholder="Password" autocomplete="current-password">
			<div class="sign-in-remember">
                <div class="checkbox-wrapper">
    				<input type="checkbox" id="remember-me" name="remember_me" class="checkbox is-hidden">
                </div>
                <span class="checkbox-label">Remember me</span>
			</div>
			<a href="#" class="sign-in-link" id="forgot-password-link">Forgotten your password?</a>
			<div class="sign-in-button-container margin-top margin-left-20 margin-bottom">
				<button type="submit" id="sign-in-button" class="sign-in-buttons general-white-orange-button">Sign In</button>
				<button type="button" id="sign-in-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
				<div class="clearfix"></div>
			</div>
			<div class="sign-in-error">Email or password not correct. Please try again</div>
			<div class="sign-in-loading">Please wait...</div>
		</form>
		<div class="forgot-password-container">
			
<script type="text/javascript">
	$(function(){
		// Note: All the setup needs to run against a name attribute and *not* the id due the clonish
		// nature of facebox...
		$("a[id=googleSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("GOOGLE");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=facebookSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("FACEBOOK");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=orcidSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("ORCID");
            $("form[id=oAuthForm]").submit();
        });
	});
</script>

<span class="text first">
	If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.
    <p>The email address should be the one you originally registered with F1000.</p>
</span>
<input name="email" class="sign-in-input" id="email-forgot-password" type="text" placeholder="Email address">
<div class="forgot-password-email-error">
	Email address not valid, please try again
</div>
<div class="forgot-password-google-email-error">
    <p>You registered with F1000 via Google, so we cannot reset your password.</p>
	<p>To sign in, please click <a href="#" id="googleSignInButton">here</a>.</p>
    <p>If you still need help with your Google account password, please click <a href="https://www.google.com/accounts/recovery">here</a>.</p>
</div>
<div class="forgot-password-facebook-email-error">
    <p>You registered with F1000 via Facebook, so we cannot reset your password.</p>
    <p>To sign in, please click <a href="#" id="facebookSignInButton">here</a>.</p>
	<p>If you still need help with your Facebook account password, please click <a href="https://www.facebook.com/recover/initiate">here</a>.</p>
</div>
<div class="clearfix"></div>
<div class="forgot-password-captcha-error">
	Code not correct, please try again
</div>
<div class="clearfix"></div>
<div class="sign-in-button-container margin-left-20 margin-bottom">
	<button type="button" id="sign-in-reset-password" class="sign-in-buttons general-white-orange-button">Reset password</button>
	<button type="button" id="forgot-password-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
	<div class="clearfix"></div>
</div>
<span class="text last">
	<a href="mailto:">Email us</a> for further assistance.
</span>
<form action="https://f1000research.com/j_spring_oauth_security_check" id="oAuthForm" method="post" target="_top">
                        <input class="target-field" type="hidden" name="target" value="/articles/5-2234.html"/>
                <input id="oAuthSystem" name="system" type="hidden"/>
</form>
			<div class="forgot-password-server-error">Server error, please try again.</div>
			<div class="sign-in-success">
                <p>We have sent an email to <span id="email-value"></span>, please follow the instructions to reset your password.</p>
                <p>If you don't receive this email, please check your spam filters and/or contact .</p>
            </div>
			<div class="sign-in-loading">Please wait...</div>
		</div>

		<div class="sign-in-form-register-section">
			<div class="sign-in-button-container margin-left-20 margin-bottom">
				<a href="/register" title="Register"><button type="button" id="sign-in-register-button" class="sign-in-buttons general-white-orange-button">Register</button></a>
				<div class="clearfix"></div>
			</div>
		</div>

	</div>
</div>

<script type="text/javascript">
$(document).ready(function () {

    signIn.createSignInAsRow($("#sign-in-form-gfb-popup"));

    $(".target-field").each(function () {
        var uris = $(this).val().split("/");
        if (uris.pop() === "login") {
        	$(this).val(uris.toString().replace(",","/"));
        }
    });
});
</script>
        <div id="templateOverlay" class="is-hidden" hidden="hidden">
  <div class="o-overlay js-overlay is-hidden" hidden="hidden"></div>
</div>

<div id="templateExternalMessages" class="is-hidden" hidden="hidden">
  <div class="o-modal o-modal--auto@md js-external-messages is-hidden" hidden="hidden">
    <div class="o-modal__body">
      <section class="c-console">
        <div class="_mdl-layout c-console__bdy js-external-messages-body"></div>
        <footer class="_mdl-layout c-console__ftr o-flex o-flex--reverse js-external-messages-footer">
          <button type="button" class="mdl-button mdl-js-button mdl-button--raised mdl-button--colored c-console__btn js-external-messages-close" data-action="maintenance-close">I Understand</button>
        </footer>
      </section>
    </div>
  </div>
</div>

<script src="https://cdnjs.cloudflare.com/ajax/libs/moment.js/2.22.1/moment.min.js"></script>

<script src="/js/namespace.js"></script>
<script src="/js/constants.js"></script>
<script src="/js/utilities.js"></script>

<script>
                  F1000.ExtenalMaintenanceItems = [
    {
      start: '2018-12-10T14:21:00Z',
      end: '2018-12-13T16:00:00Z',
      msg: 'This site will be down for a short time on XX December. It is advisable not to start any submissions on that day or you may lose your work unless you save regularly.',
      cookieName: 'outage23122018',
      editor: false,
    }
  ];
</script>

<script src="/js/shared_scripts/cookie-helper.js"></script>
<script src="/js/shared_scripts/mdl-helper.js"></script>

<script src="/js/app/external-maintenance.js"></script>

                <script type="text/javascript">
            (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
            (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
            m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
            })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

            ga('create', 'UA-5646075-11', 'auto');
            ga('require', 'displayfeatures');
            ga('send', 'pageview');
        </script>
        
                <script type="text/javascript" src="/js/app/research.analytics.js"></script>

        <!-- Start of HubSpot Embed Code -->
        <script type="text/javascript" id="hs-script-loader" async defer src="//js.hs-scripts.com/4475190.js"></script>
        <!-- End of HubSpot Embed Code -->
    
            <script src="https://my.hellobar.com/4e0495c6f18cbd68731a1dc1978195a144e767ba.js" type="text/javascript" charset="utf-8" async="async"></script>
    </body>

</html>